Skip to main content
SpringerLink
Log in

L

  • Chapter
Hagers Handbuch der Pharmazeutischen Praxis

  • 202 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 84.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Semeraro C, Micheli D, Pieraccioli D, Gaviraghi G, Borthwick AD, verschiedene Patente zit. in (1989) Drugs Fut 14:317–321

    Google Scholar 

  2. Gross P, Pellegati M, Vigelli G, Ayrton J, Duncan BA, Evans GL, Maltas J (1992) Xenobiotica 22:899–916

    Article  Google Scholar 

  3. Lee CR, Bryson HM (1994) Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension. Drugs 48:274–296

    Article  PubMed  CAS  Google Scholar 

  4. Godfraind T, Salomone S (1991) Functional interaction of lacidipine with calcium channels in vascular smooth muscle. J Cardiovasc Pharmacol 18 Suppl 11:S1–S6

    Article  PubMed  CAS  Google Scholar 

  5. Micheli D, Collodel A, Semeraro C, et al. (1990) Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies. J Cardiovasc Pharmacol 15:666–675

    Article  PubMed  CAS  Google Scholar 

  6. Micheli D, Massagrande M, Giacometti A, et al. (1992) A comparative study on the vascular selectivity of lacidipine in the pithed rat. Pharmacology 44:150–157

    Article  PubMed  CAS  Google Scholar 

  7. Hall ST, Harding SM, Ebans GL, et al. (1991) Clinical pharmacology of lacidipine. J Cardiovasc Pharmacol 17 Suppl 4:S9–S13

    PubMed  CAS  Google Scholar 

  8. Lyons D, Fowler G, Webster J, et al. (1994) An assessment of lacidipine and atenolol in mild to moderate hypertension. Br J Clin Pharmacol 37:45–51

    Article  PubMed  CAS  Google Scholar 

  9. Chiariello M, Southern Italian Lacidipine Study Group (1991) A double-blind comparison of the efficacy and safety of lacidipine and hydrochlorothiazide in essential hypertension. J Cardiovasc Pharmacol 17 Suppl 4:S35–S37

    PubMed  Google Scholar 

  10. United Kindgom Ladicidpine Study Group (1991) A double blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. J Cardiovasc Pharmacol 17 Suppl 4:S27–S30

    Google Scholar 

  11. Leonetti G, Northern Italian Study Group of Lacidipine in Hypertension (1991) Comparative study of lacidipine and nifedipine SR, in the treatment of hypertension: an Italian multicenter study. J Cardiovasc Pharmacol 17 Suppl 4:S31–S34

    PubMed  Google Scholar 

  12. Leonetti G, Salvi S (1994) A long-term study comparing lacidipine an nifedipine SR in hypertensive patients. Safety data. J Cardiovasc Pharmacol 23 Suppl 5:S108–S110

    Article  PubMed  CAS  Google Scholar 

  13. Endersby CA, Brown EG, Perelman MS (1991) Safety profile of lacidipine: a review of clinical data. J Cardiobasc Pharmacol 17 Suppl 4:S45–S47

    Google Scholar 

  14. von Falbe J, Regitz M; Römpps Chemie-Lexikon, 9. Aufl. Georg Thieme Verlag, Stuttgart

    Google Scholar 

  15. Musso H und Mitarbeiter (1961) Angewandte Chemie 73:665

    Article  Google Scholar 

  16. Beilstein Grundwerk, 13:491

    Google Scholar 

  17. Hesse E (1930) Zur biologischen Wertbestimmung der Analgetika und ihre Kombinationen. 1. Mitteilung. Nauny-Schmiedeberg’s Arch exp Pharmak 158:233–246

    Article  CAS  Google Scholar 

  18. Hausschild F (1958) Pharmakologie und Grundlagen der Toxikologie, VEB Georg Thieme, Leipzig

    Google Scholar 

  19. von Jaksch R (1894) Über die Behandlung des Typhus abdominalis mit Laktophenin. Zentrallblatt für Innere Medizin 15:233–236

    Google Scholar 

  20. Brand K (1950) Über Arylamide der 1(+) — Milchsäure und deren therapeutischen Wirkung. Angewandte Chemie 62:447 (abstract)

    Google Scholar 

  21. Koll W, Fleischmann G (1941) Messungen der analgetischen Wirksamkeit einiger Antipyretica am Hund. Naunyn ∼ Schmiedebergis Arch exp Pharmakol 198:390–406

    Article  CAS  Google Scholar 

  22. Strauss H (1894a) Über Lactophenin. Therapeutische Monatshefte 8:442–445

    Google Scholar 

  23. Fränkel S (1921) Die Arzneimittel-Synthese. Auf Grundlage der Beziehung zwischen chemischen Aufbau und Wirkung. 5. Auflage, Verlag-Julius-Springer, Berlin

    Google Scholar 

  24. Laache S (1904) Zur Pathogenese des Laktopheninicterus. Deutsche medizinische Wochenschrift, 1808-1810

    Google Scholar 

  25. Hinsberg O, Treupel G (1894) Über die physiologische Wirkung des p-Aminophenols und einiger Derivate desselben. Arch exp Pathologie und Pharmakologie 33:216–250

    Google Scholar 

  26. Strauss H (1894b) Über Lactophenin. Therapeutische Monatshefte 8:509–513

    Google Scholar 

  27. Strauss H (1895) 3 Fälle von Icterus catarrhalis während des Gebrauchs von Lactophenin. Therapeutische Monatshefte 9:469–471

    Google Scholar 

  28. Camero JM, Collis P, Daniel M, Storer R, Wilcox P (1993) Drugs Fut 18:319–323

    Google Scholar 

  29. Coates JAV, Mutton IM, Penn CR, Storer R, Williamson C (1992) PCT Int Appl, zit. nach CA (1992) 117:111989

    Google Scholar 

  30. Mahmoudian M, Baines BS, Drake CS, Hale RS, Jones P, Piercey JE, Montgomery DS, Purvis IJ, Storer R et al. (1993) Enzyme Microb Technol 15:749–755

    Article  PubMed  CAS  Google Scholar 

  31. Storer R, Clemens IR, Lamont B, Noble SA, Williamson C, Belleau B (1993) Nucleosides Nucleotides 12:225–236

    Article  CAS  Google Scholar 

  32. Milton J, Brand S, Jones MF, Rayner CM (1995) Tetrahedron (Asymmetry) 6:1903–1906

    Article  CAS  Google Scholar 

  33. Cousins RPC, Mahmoudian M, Youds PM (1995) Tetrahedron (Asymmetry) 6:393–396

    Article  CAS  Google Scholar 

  34. Coates JAV, Cammack M, Jenkinson HJ, Mutton IM, Pearson BA, Storer R, Cameron JM, Penn CR (1992) Antimicrobial Agents Chemother 36:202–205

    Article  CAS  Google Scholar 

  35. Jozwiakowski MJ, Nguyen NT, Sisco JM, Spancake CW (1996) J Pharm Sci 85:193–199

    Article  PubMed  CAS  Google Scholar 

  36. Nguyen NT, Wells ML, Cooper DC (1995) Drug Dev Ind Pharm 21:1671–1682

    Article  CAS  Google Scholar 

  37. Altria KD, Trylen E, Turner N (1995) Chromatographia 41:393–397

    CAS  Google Scholar 

  38. Altria KD, Franke P, Gill I, Hadgett T, Kelly MA (1995) J Pharm Biomed Anal 13:951–957

    Article  PubMed  CAS  Google Scholar 

  39. Hsyu P, Lloyd TL (1994) J Chromatogr B 655:253–260

    Article  CAS  Google Scholar 

  40. Moris DM, Selinger K (1994) J Pharm Biomed Anal 12:255–264

    Article  Google Scholar 

  41. Soudeyns H, Yao XI, Gao Q, Belleau B, Kraus JL, Nguyen-Ba N, Spira B, Wainberg MA (1991) Anti-human immunodeficiency virus type 1 activity and in vitro toxicity of 2′-deoxy-3′-thiacytidine (BCH-189), a novel heterocyclic nucleoside analog. Antimicrob Agents Chemother 35:1386–1390

    Article  PubMed  CAS  Google Scholar 

  42. Moyle G (1996) Activity and role of lamivudine in the treatment of adults with human immunodeficiency virus type 1 infection, a review. Expert Opin Invest Drug 5:913–924

    Article  CAS  Google Scholar 

  43. Merrill DP, Moonis M, Chou TC, Hirsch MS (1996) Lamivudine or stavudine in two-and three-drug combinations against human immunodeficiency virus type 1 replication in vitro. J Infect Dis 173:355–364

    Article  PubMed  CAS  Google Scholar 

  44. Yuen GJ, Morris DM, Mydlow PK, Haidar S, Hall ST, Hussey EK (1995) Pharmacokinetics, absolute bioavailability, and absorption characteristics of lamivudine. J Clin Pharmacol 35:1174–1180

    Article  PubMed  CAS  Google Scholar 

  45. van Leeuwen R, Lange JM, Hussey EK, Donn KH, Hall ST, Harker AJ, Jonker P, Danner SA (1992) The safety and pharmacokinetics of a reverse transcriptase inhibitor, 3TC, in patients with HIV infection: a phase I study. AIDS 6:1471–1475

    Article  PubMed  Google Scholar 

  46. Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M (1995) A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med 333:1657–1661

    Article  PubMed  CAS  Google Scholar 

  47. Glaxo Wellcome (1996) Fachinformation Epivir

    Google Scholar 

  48. Heald AE, Hsyu PH, Yuen GJ, Robinson P, Mydlow P, Bartlett JA (1996) Pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with renal dysfunction. Antimicrob Agents Chemother 40:1514–1519

    PubMed  CAS  Google Scholar 

  49. Katlama C, Ingrand D, Loveday C, Clumeck N, Mallolas J, Staszewski S, Johnson M, Hill AM, Pearce G, McDade H (1996) Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group. JAMA 276:118–125

    Article  PubMed  CAS  Google Scholar 

  50. Bartlett JA, Benoit SL, Johnson VA, Quinn JB, Sepulveda GE, Ehmann WC, Tsoukas C, Fallon MA, Self PL, Rubin M (1996) Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party. Ann Intern Med 125:161–172

    Article  PubMed  CAS  Google Scholar 

  51. Staszewski S, Loveday C, Picazo JJ, Dellarnonica P, Skinhoj P, Johnson MA, Danner SA, Harrigan PR, Hill AM, Verity L, McDade H (1996) Safety and efficacy of lamivudine-zidovudine combination therapy in zidovudine-experienced patients. A randomized controlled comparison with zidovudine monotherapy. Lamivudine European HIV Working Group. JAMA 276:111–117

    Article  PubMed  CAS  Google Scholar 

  52. Moore KH, Yuen GJ, Raasch RH, Eron JJ, Martin D, Mydlow PK, Hussey EK (1996) Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole. Clin Pharmacol Ther 59:550–558

    Article  PubMed  CAS  Google Scholar 

  53. Taburet AM, Singlas E (1996) Drug interactions with antiviral drugs. Clin Pharmacokinet 30:385–401

    Article  PubMed  CAS  Google Scholar 

  54. Gessner O, Orzechowski G (1974) Gift-und Arzneipflanzen von Mitteleuropa, 3. Aufl., Carl-Winter-Universitäts-verlag, Heidelberg

    Google Scholar 

  55. Banek M, Michalak D, Wojtczak S, Tucholski K, Wyrzykowska B (1984) PL 84-248021; zit. nach CA 112 (14):125180w

    Google Scholar 

  56. Sterba J, Pitra J (1960) CS 60–5570; zit. nach CA 112 (16): 1455496

    Google Scholar 

  57. Kaminski M, Sledzinska B, Klawiter J (1986) J Chromatogr 367(1):45–58

    PubMed  CAS  Google Scholar 

  58. Pachaly P (1983) Dünnschichtchromatographie in der Apotheke, 2. Aufl., Wissenschaftliche Verlagsgesellschaft Stuttgart

    Google Scholar 

  59. Kartnig T, Kobosil P (1977) J Chromatogr 138(1):238–242

    Article  PubMed  CAS  Google Scholar 

  60. Solich P, Karlicek R (1987) Cesk Farm 36(7):323–327; zit. nach CA 107 (26):242702a

    Google Scholar 

  61. Solich P, Karlicek R, Jokl V (1988) Cesk Farm 37(5):193–197; zit. nach CA 109 (16):135044g

    CAS  Google Scholar 

  62. Orosz F, Nuridsany M, Ovadi J (1986) Anal Biochem 156(1): 171–175; zit. nach CA 105 (10):85252t

    Article  PubMed  CAS  Google Scholar 

  63. Poetter H, Baerisch H (1972) Pharmazie 27(5):315–318

    CAS  Google Scholar 

  64. Machovicova F (1966) Farm Obz 35(10):450–453; zit. nach CA 66 (18):79634d

    CAS  Google Scholar 

  65. Weiler EW, Zenk MH (1976) Phytochemistry 15(10): 1537–1545

    Article  CAS  Google Scholar 

  66. Seo A, Sugano H, Hasegawa N, Ikeda K et al. Jpn Kokai Tokkyo Koho, 12 pp, 62093204 A2 870428 Showa; zit. nach CA 107:217627

    Google Scholar 

  67. Drugs Fut (1993) 18:222225

    Google Scholar 

  68. Ohmi T, Konaka S, Uchida M, Yamaguchi H (1991) Antifungal activity of the new agent lanoconazole in two tinea models. Arzneim-Forsch 41:847–851

    CAS  Google Scholar 

  69. Mar31

    Google Scholar 

  70. CoyDH, Murphy WA, Heiman ML; EP 214872, EP 215171, JP 87061997; Bogden AE, Moreau JP; EP 542934, WO 9213554 (1994) Drugs Fut 19(11):992-999

    Google Scholar 

  71. Drags Fut (1994) 19(11):992-999

    Google Scholar 

  72. Viollet C, Prevost G, Maubert E, Faivre-Bauman A, Gardette R, Kordon C, Loudes C, Slama A, Eperlbaum J (1995) Molecular pharmacology of somatostatin receptors, Fundam Clin Pharmacol 9(2): 107–113

    Article  PubMed  CAS  Google Scholar 

  73. Kuhn JM, Basin C, Mollard M, Rouge B de, Baudoin C, Obach R (1993) Pharmacokinetic study and effects on growth hormone secretion in healthy volunteers of the new somatostatin analouge BIM 23014, Eur J Clin Pharmacol 45(1):73–77

    Article  PubMed  CAS  Google Scholar 

  74. Johnson MR, Chowdrey HS, Thomas F, Grint C, Ligthman SL (1994) Pharmacokinetics and efficacy of the long-acting somatostatin analogue somatuline in acromegaly, Eur J Endocrinol 130(3):229–235

    Article  PubMed  CAS  Google Scholar 

  75. Baudouin C, Imbert F, Ettaiche M, Gastaud P (1995) Evaluation of antiproliferative effects of the somatostatin analog-somatuline in a rabbit model of traction retinal detachment, Fundam Clin Pharmacol 9(4):357–365

    Article  PubMed  CAS  Google Scholar 

  76. Karalis K, Mastorakos G, Chrousos GP, Tolis G (1994) Somatostatin analogues suppress the inflammatory reaction in vivo, J Clin Investigation 93:2000–2006

    Article  CAS  Google Scholar 

  77. Imam H, Erksson B, Janson ET, Lindgren PG, Wilander E, Oberg K (1995) Study of apoptosis in neuroendocrine gut tumors during biotherapy, Proc Am Assoc Cancer Res 36,38 Meet, 16

    Google Scholar 

  78. Sator AO, Fiff WD, Thirbault A, Cooper MR, Headlee D, Myers CE (1994) A phase I study of Somatuline in patients with metastatic androgen-resistant prostate cancer, Clin Pharmacol Ther 55(2): 190

    Google Scholar 

  79. Anthony LB, Krozley MG, Johnson DH, Shaff MI, Hande KR, Oates JA (1992) Somatuline’s antitumor efficacy and phase I trial in neuroendocrine tumors, Proc Am Soc Clin Oncol 11(28 Meet): 167

    Google Scholar 

  80. Canobbio L, Cannnata D, Miglietta L, Boccardo F (1995) Somatuline (BIM 23014) and tamoxifen treatment of postmenopausal breast cancer patients: clinical activity and effect on insulin-like growth factor-I (IGF-I) levels, Anticancer 15(6B):2687–2690

    CAS  Google Scholar 

  81. Figg WD, Thibault A, Cooprer MR, Reid R, Headlee D, Dawson N, Kohler DR, Reed E, Sartor O (1995) A phase I study of the somatostatin analogue somatuline in patients with metastatic hormone-refractory prostate cancer, Cancer 75(89):2159–2164

    Article  PubMed  CAS  Google Scholar 

  82. Takeda Chem Ind., Ltd. (Japan); Tap Pharm. (USA) (1989) Drug Fut 14:625–627

    Google Scholar 

  83. Wissenschaftliche Basisbroschüre der Fa. Takeda Pharma

    Google Scholar 

  84. Landes BD, Miscoria G, Flouvat B (1992) J Chromatogr 577:117–122

    Article  PubMed  CAS  Google Scholar 

  85. Aoki I, Okumura M, Yashiki T (1991) J Chromatogr 571:283–290

    Article  PubMed  CAS  Google Scholar 

  86. Nagaya H, Satoh H, Kubo K, Maki Y (1989) J Pharmacol Exp Ther 248:799–805

    PubMed  CAS  Google Scholar 

  87. Satoh H, Inatomi N, Nagaya H, Inada I, Nohara A, Nakamura N, Maki Y (1989) J Pharmacol Exp Ther 248:806–815

    PubMed  CAS  Google Scholar 

  88. Nagaya H, Inatomi N, Satoh H (1991) Jpn J Pharmacol 55:425–436

    Article  PubMed  CAS  Google Scholar 

  89. Sanders SW, Tolman KG, Greski PA, Jennings DE, Hoyos PA, Page G (1992) Aliment Pharmacol Ther 6:359–372

    Article  PubMed  CAS  Google Scholar 

  90. Iwahi T, Satoh H, Nakao M, Iwasaki T, Yamazaki T, Kubo K, Tamura T, Imada A (1991) Antimicrob Agents Chemother 35:490–496

    Article  PubMed  CAS  Google Scholar 

  91. Landes BD, Petite JP, Flouvat B (1995) Clin Pharmacokinet 28:458–470

    Article  PubMed  CAS  Google Scholar 

  92. Spencer CM, Faulds D (1994) Drugs 48:404–430

    Article  PubMed  CAS  Google Scholar 

  93. Jaup BH, Norrby A (1995) Gastroenterology 108:A123

    Article  Google Scholar 

  94. Colin-Jones (1993) Aliment Pharmacol Ther 7(Suppl 1):56–60

    PubMed  Google Scholar 

  95. Fachinformation Agopton/Agopton 15, Takeda Pharma (1994)

    Google Scholar 

  96. Taylor EP (1952) J Chem Soc 142

    Google Scholar 

  97. Clarke’s Isolation and Identification of Drugs in Pharmaceuticals, Bodyfluids and Post Mortem Material, (1986) 2. Aufl., S.389

    Google Scholar 

  98. Dale, Meara (1955) J Sci Food Agr 6:162

    Article  CAS  Google Scholar 

  99. Drugs Fut (1984) 9:339-341

    Google Scholar 

  100. Liu DL, Andersson-Engels S, Sturesson C et al. (1997) Cancer Lett 111:157–65

    Article  PubMed  CAS  Google Scholar 

  101. Steward AT, Hauser CR (1955) Am Soc 77:1098–1100

    Article  Google Scholar 

  102. Hauser CR et al. (1955) J Org Chem 20:1119–1127

    Article  CAS  Google Scholar 

  103. Goodson C (1950) Am Soc 72:358

    Article  CAS  Google Scholar 

  104. Snyder R (1950) Am Soc 72:2958–2960

    Article  CAS  Google Scholar 

  105. Beil Erg. Werk 3, Bd. 12, S.3243

    Google Scholar 

  106. Mar31, S.57

    Google Scholar 

  107. Bartlett RR, Brendel S, Zielinski T et al. (1996) Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis. Transpl Proc 28:3074–3078

    CAS  Google Scholar 

  108. Burkhardt H, Kalden JR (1997) Xenobiotic immunosuppressive agents: therapeutic effects in animal models of autoimmune diseases. Rheumatol Int 17:85–90

    Article  PubMed  CAS  Google Scholar 

  109. Cao WW, Kao PN, Aoki Y et al. (1996) A novel mechanism of action of the immunosuppressive drug, leflunomide: Augmentation of the immunosupressive cytokine, TGF-β1, and suppression of the immunostimulatory cytokine, IL-2. Transpl Proc 28:3079–3080

    CAS  Google Scholar 

  110. Chong AS, Finnegan A, Jiang X et al. (1993) Leflunomide, a novel immunosuppressive agent. The mechanism of inhibition of T cell proliferation. Transplant 55:1361–1366

    Article  CAS  Google Scholar 

  111. Choy EH, Scott DL (1997) Drug treatment of rheumatic diseases in the 1990s. Achievements and future developments. Drags 53:337–348

    Article  CAS  Google Scholar 

  112. Curnock AP, Robson PA, Yea CM et al. (1997) Potencies of leflunomide and HR325 as inhibitors of prostaglandin endoperoxide H synthase-1 and-2: comparison with nonsteroidal anti-inflammatory drags. J Pharmacol Exp Ther 282:339–347

    PubMed  CAS  Google Scholar 

  113. Davis JP, Cain GA, Pitts WJ et al. (1996) The immunosuppressive metabolite of leflunomide is a potent inhibitor of human dihydroorotate dehydrogenase. Biochem 35:1270–1273

    Article  CAS  Google Scholar 

  114. Furst DE (1995) Innovative treatment approaches for rheumatoid arthritis. Cyclosporin, leflunomide and nitrogen mustard. Baillieres Clin Rheumatol 9:711–729

    Article  PubMed  CAS  Google Scholar 

  115. Herrmann DB, Bicker U (1990) Drags in autoimmune diseases. Klin Wschr 68: Suppl 21, 15–25

    PubMed  Google Scholar 

  116. Lin Y, Vandeputte M, Waer M (1998) Accomodation and T-independent B cell tolerance in rats with long term surviving hamster heart xenografts. J Immunol 160:369–375

    PubMed  CAS  Google Scholar 

  117. Lucien J, Dias VC, LeGatt DF et al. (1995) Blood distribution and single-dose pharmacokinetics of leflunomide. Ther Drag Monit 17:454–459

    Article  CAS  Google Scholar 

  118. Morris RE (1995) Mechanisms of action of new immunosuppressive drags. Ther Drag Monit 17:564–569

    Article  CAS  Google Scholar 

  119. Rozman B (1998) Clinical experience with leflunomide in rheumatoid arthritis. Leflunomide Investigator’s Group. J Rheumatol, suppl 1998, 53:27–32

    CAS  Google Scholar 

  120. Ruckemann K, Fairbanks LD, Carrey EA et al. (1998) Leflunomide inhibits pyrimidine de novo synthesis in mitogen-stimulated T-lymphocytes from healthy humans. J Biol Chem 273:21682–21691

    Article  PubMed  CAS  Google Scholar 

  121. Siemasko K, Chong AS, Jack HM et al. (1998) Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgGl production. J Immunol 160:1581–1588

    PubMed  CAS  Google Scholar 

  122. Silva HT, Shorthouse R, Morris RE (1996) Single-and multiple-dose pharmacokinetics and pharmacodynamics of leflunomide’s active metabolite A77 1726 in normal Lewis rats. Transpl Proc 28:3092–3094

    CAS  Google Scholar 

  123. Strand V (1997) Approaches to the management of systemic lupus erythematosus. Curr Opin Rheumatol 9:410–420

    Article  PubMed  CAS  Google Scholar 

  124. Uhlig T, Cooper D, Eber E et al. (1998) Effects of longterm oral treatment with leflunomide on allergic sensitization, lymphocyte activation, and airway inflammation in a rat model of asthma. Clin Exp Allergy 28:758–764

    Article  PubMed  CAS  Google Scholar 

  125. Vidic-Dankovic B, Kosec D, Damjanovic M et al. (1995) Leflunomide prevents the development of experimentally induced myasthenia gravis. Int J Immunopharmacol 17:273–281

    Article  PubMed  CAS  Google Scholar 

  126. Wennberg L, Karlsson-Parra A, Sundberg B et al. (1997) Efficacy of immunosuppressive drags in islet xenotransplantation: leflunomide and mycophenolate mofetil prevents islet xenograft rejection in the pig-to-rat model. Transplantation 63:1234–1242

    Article  PubMed  CAS  Google Scholar 

  127. Buu-Hoi NP, Rips R, Cavier R (1959) J Med Pharm Chem 1:23–30

    Article  PubMed  CAS  Google Scholar 

  128. Magnin P, Rips R, Nicod B, Egreteau JP (1962) Ann Sci Univ Besancon Med 6:105–112

    CAS  Google Scholar 

  129. Souza LM et al. (1986) Science 232:61–65

    Article  PubMed  CAS  Google Scholar 

  130. Weite K, Platzer E, Li L, Gabrilove JL, Levi E, Mertelsmann R, Moore MAS (1985) Proc Natl Acad Sci 82:1526–1530

    Article  Google Scholar 

  131. Fricke U, Klaus W (1994) Neue Arzneimittel 1994, Wissenschaftliche Verlagsgesellschaft mbH Stuttgart, S.274-274

    Google Scholar 

  132. Schulz M, Peruche B (1995) PZ 140:1024–1027

    Google Scholar 

  133. de Arriba F, Lozano ML, Ortuno F et al. (1997) Prospective randomized study comparing the efficacy of bioequivalent doses of glycosylated and nonglycosylated rG-CSF for mobilizing peripheral blood progenitor cells. Brit J Haematol 96:418–420

    Article  Google Scholar 

  134. Avalos BR, Hedzat C, Baldwin GC, Golde DW, Gasson JC, DiPersio JF (1987) Biological activities of human G-CSF and characterization of the human G-CSF receptor, Blood 70:165a (Abstr)

    Google Scholar 

  135. Bonilla MA, Gilio AP, Ruggiero M, Kernan NA, Brochstein JA, Abboud M, Fumagalli L, Vincent M, Gabrilove JL, Weite K (1989) Effects of recombinant human granulocyte colony-stimulating factor on neutropenia in patients with congenital agranulocytosis, N Engl J Med 320:1574–1580

    Article  PubMed  CAS  Google Scholar 

  136. Frampton JE, Yarker YE, Goa KL (1995) Lenograstim. A review of its pharmacological properties and therapeutic efficacy in neutropenia and related clinical settings. Drugs 49:767–793

    Article  PubMed  CAS  Google Scholar 

  137. Hakansson L, Hoglund M, Jonsson UB et al. (1997) Effects of in vivo administration of G-CSF on neutrophil and eosinophil adhesion. Brit J Haematol 98:603–611

    Article  CAS  Google Scholar 

  138. Ishikawa K, Tanaka H, Matsuoka T et al. (1998) Recombinant human granulocyte colony-stimulating factor attenuates inflammatory responses in septic patients with neutropenia. J Trauma 44:1047–1054

    Article  PubMed  CAS  Google Scholar 

  139. Layton JE, Hockman H, Sheridan WP, Morstyn G (1989) Evidence for a novel in vivo control mechanism of granulopoiesis; mature cell-related control of a regulatory growth factor, Blood 74:1303–1307

    PubMed  CAS  Google Scholar 

  140. Lieschke GJ, Burgess AW (1992) Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor, N Engl J Med 327:28–35 und 99-106

    Article  PubMed  CAS  Google Scholar 

  141. Lindemann A, Herrmann F, Oster W, Haffner G, Meyenburg W, Souza LM, Mertelsmann R (1989) Hematologic effects of recombinant human granulocyte colony-stimulating factor in patients with malignancy, Blood 74:2644–2651

    PubMed  CAS  Google Scholar 

  142. Lord BI, Bronchud MH, Owens S, Chang J, Howell A, Souza L, Decter TM (1989) The kinetics of human granulopoiesis following treatment with granulocyte colony-stimulating factor in vivo, Proc Nat Acad Sci US 86:9499–9503

    Article  CAS  Google Scholar 

  143. Lord BI, Gourney H, Chang J, Thatcher N, Corwther D, Dexter TM (1992) Haemopoietic cell kinetics in humans treated with GM-CSF, Int J Cancer 50:26–31

    Article  PubMed  CAS  Google Scholar 

  144. Metcalf D (1989) The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells, Nature 339:27–30

    Article  PubMed  CAS  Google Scholar 

  145. Morstyn G, Campbell I, Lieschke G, Layton JE, Meher D, O’Connor M, Green M, Sheridan W, Vincent M, Alton K, Souza L, McGrath K, Fox RM (1989) Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration therapy, J Clin Oncol 7:1554–1562

    PubMed  CAS  Google Scholar 

  146. Nissen C (1994) Glycosylation of recombinant human granulocyte colony stimulating factor: implications for stability and potency. Eur J Cancer 30A, Suppl 3, S. 12–14

    Google Scholar 

  147. Negrin RS, Haeuber DH, Nagler A, Kobayashi Y, Sklar J, Donlon T, Vincent M, Greenberg PL (1990) Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor. Blood 76:36–43

    PubMed  CAS  Google Scholar 

  148. Sheridan WP, Morstyn G, Wolf M, Dodds A, Lusk J, Maher D, Layton JE, Green MD, Souza L, Fox RM (1989) Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet II:891–895

    Article  Google Scholar 

  149. Masaoka T, Moriyama Y, Kato S (1990) A randomized placebo-controlled study of KRN 8601 (recombinant human granulocyte colony-stimulating factor) in patients receiving allogenic bone marrow transplantation. Jap J Med 3:233–239

    Google Scholar 

  150. Baldwin GC, Gasson JC, Quan SG, Fleischmann J, Weisbart R, Oette D, Mitsuyasu RT, Golde DW (1988) Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients. Proc Nat Acad Sci 85:2763–2766

    Article  PubMed  CAS  Google Scholar 

  151. Miles SA, Mitsuyasu RT, Moreno J, Baldwin G, Alton NK, Souza L, Glaspy JA (1991) Combined therapy with recombinant granulocyte colony-stimulating factor and erythropoietin decreases hématologie toxicity from zidovudin. Blood 77:2109–2117

    PubMed  CAS  Google Scholar 

  152. Sasaki O, Yokoyama A, Uemura S et al. (1994) Drug eruption caused by recombinant human G-CSF. Int Med 33:641–643

    Article  CAS  Google Scholar 

  153. Stanworth SJ, Bhavnani M, Chattopadhya et al. (1998) Treatment of Felty’s syndrome with the haemopoetic growth factor granulocyte colony-stimulating factor (GCSF). Quart J Med. 91:49–56

    Article  CAS  Google Scholar 

  154. Stoudemire JB (1992) Pharmacokinetics and metabolism of hematopoetic proteins. In: Bobbe L, Ferraiolo L (Hrsg.) Protein pharmacokinetics and metabolism, Plenum Press, New York, S. 189–222

    Google Scholar 

  155. Stute N, Santana VM, Rodman JH, Schell MJ, Ihle JN, Evans WE (1992) Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children. Blood 79:2849–2854

    PubMed  CAS  Google Scholar 

  156. Theocharis SE, Agapitos EB, Margeli AP et al. (1997) Effect of two forms of granulocyte-colony-stimulating factor on hepatic regneration after 70 % partial hepatectomy in rats. Clin Sci 92:315–320

    PubMed  CAS  Google Scholar 

  157. Toner GC, Shapiro JD, Laidlaw CR et al. (1998) Low-dose versus standard-dose lenograstim prophylaxis after chemotherapy: a randomized, crossover comparison. J Clin Oncol 16:3874–3879

    PubMed  CAS  Google Scholar 

  158. Nohynek GJ, Plard JP, Wells MY et al. (1997) Comparison of the potency of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factors in neutropenic and nonneutropenic CD rats. Cancer Chemoth Pharmacol 39:259–266

    Article  CAS  Google Scholar 

  159. Ohsaka A, Kitawa S, Sakamoto S, Miura Y, Takanashi N, Takaku F, Saito M (1989) In vivo activation of human neutrophil functions by adminstration of recombinant human granulocyte colony-stimulating factor in patients with malignant lymphoma, Blood 74:2743–2748

    PubMed  CAS  Google Scholar 

  160. Okada Y, Kawagishi M, Kusaka M (1990) Effect of recombinant human granulocyte colony-stimulating factor on human neutrophil adherence in vitro. Exper 46:1050–1053

    Article  CAS  Google Scholar 

  161. Ono M (1994) Physicochemical and biochemical characteristics of glycosylated recombinant human granulocyte colony stimulating factor (lenograstim). Eur J Cancer 30A, Suppl 3, S.7–11

    Google Scholar 

  162. Boeckx GM, Raeymaekers AHM, Sipido V (1986) Eur Pat Appl EP 170,316; zit. nach CA 105:60637j

    Google Scholar 

  163. Haberkorn A (1996) Chemotherapy of human and animal coccidiosis: state and perspectives. Parasitol Res 82:193–199

    Article  PubMed  CAS  Google Scholar 

  164. Chermette R, Boufassa-Ouzerout S (1988) Cryptosporidiosis: a cosmopolitan disease in animals and in man. In: Technical Report Series, Vol. 5, 2nd edition, Office International des Epizooties, Paris 1988

    Google Scholar 

  165. O’Donoghue PJ (1995) Cryptosporidium and cryptosporidiosis in man and animals. Int. J Pariasitol 25:139–195

    Article  Google Scholar 

  166. Guillem S, Gomez M, Romeu J, Raventos A, Fernadnes A, Condom MJ, Clotet B (1992) Letrazuril for the treatment of severe cryptosporidial diarrhoea in AIDS. (Abstract PoB 3257) Int Conf AIDS 8: B129

    Google Scholar 

  167. Harris M, Deutsch G, MacLean JD, Tsoukas CM (1994) A phase I study of letrazuril in AIDS-related cryptosporidiosis. AIDS 8:1109–1113

    Article  PubMed  CAS  Google Scholar 

  168. Raventos A, Roseu J, Estrade O, Sierra G, Gomesz G, Condom MJ, Clotet B (1992) Survival of AIDS patients with enteric Cryptosporidium identification. (Abstract PO-B10-1430) Int Conf AIDS 8: B126

    Google Scholar 

  169. Rubbert A, Schwab J, Kalden JR, Nuesslein H (1993) Myositis, fever, rash and thrombopenia after letrazuril treatment of intestinal cryptosporidiosis: a case report. (Abstract PO-B10-1430) Int. Conf. AIDS 9:373

    Google Scholar 

  170. Walach C, Loeb M, Phillips J, Salit I Rachlis A, Fong I, Walmsley S (1993) Use of letrazuril in refractory cryptosporidiosis in AIDS. (Abstract PO-B 10-1472) Int Conf AIDS 9: 380

    Google Scholar 

  171. Hamour AA, Bonnington A, Hawthorne B, Wilkins EG (1993) Successful treatment of AIDS-related cryptosporidial sclerosing cholangitis. AIDS 7:1449–1451

    Article  PubMed  CAS  Google Scholar 

  172. Van de Velde V, Van Peer A, Van Rooy P (1991) Phase I study: oral bioavailability and pharmacokinetics of letrazuril from a pellet capsule in healthy volunteers. Part I: Pharmacokinetics. Beerse: Janssen Research Foundation

    Google Scholar 

  173. Victor GH, Conway B, Hawless-Foss NC, Manion D, Sahai J (1993) Letrazuril therapy for cryptosporidiosis: clinical response and pharmacokinetics. AIDS 7:438–439

    Article  PubMed  CAS  Google Scholar 

  174. Harris M, Deutsch G, MacLean JD, Tye L, Tsoukas CM (1993) A phase I study of Letrazuril in AIDS-related cryptosporidiosis. (Abstract WS-B13-5) Int Conf AIDS 9:56

    Google Scholar 

  175. Hamour AA, Khoo S, Bonnington A, Barnes A, Fraser I, Bailey G, Wilkins EG, Denning DW, Dunbar EM, Mandai BK (1992) Sucessful management of AIDS-related sclerosing cholangitis with paromomycin and letrazuril. (Abstract PuB 7229) Int. Conf. AIDS 8:87

    Google Scholar 

  176. Loeb M, Walach C, Phillips J, Fong I, Salit-Rachlis A, Walmsley S (1995) Treatment with letrazuril of refractory cryptosporidial diarrhoea. J Aquired Immune Deficiency Syndr. and Human Retrovirology 10:48–53

    CAS  Google Scholar 

  177. Baurain R, Trouet A (Inst Int Pathol Cell Molec) (1979) BE 869485, BE 2930637, BE 869485, zit.nach CA 91: 57429e (1980) BE 2930637 zit. nach CA 93: 72206 g

    Google Scholar 

  178. Castañer J, Castañer RM, Prous J (1993) Drugs Fut 18:116–120

    Google Scholar 

  179. Fellous R (1974) Franz Pat 2224472, zit. nach CA (1975) 82:156317n

    Google Scholar 

  180. Bullock MW, Hand JJ, Waletzky (1968) J Med Chem 11:169–171

    Article  PubMed  CAS  Google Scholar 

  181. Bullock MW (1969) Brit Pat 1152544, zit. nach CA (1969) 71:61383s

    Google Scholar 

  182. Brit. Pat (1969) 1169310, zit. nach CA (1970) 72:55453s

    Google Scholar 

  183. Franz. Pat (1969) 2001916, zit. nach CA (1979) 72:100700h

    Google Scholar 

  184. Fogassy E, Acs M, Felmeri J, Aracs Z (1976) Period Polytech, Chem Eng 20:247–253, zit. nach CA (1977) 87:68233e

    CAS  Google Scholar 

  185. Van der Veken GJL, Guns, EJ, Willemsens ALA (1985) Eur Pat 142191, zit. nach CA (1986) 104:68855d

    Google Scholar 

  186. Ashwood VA, Buckingham RE, Cassidy F, Evans JM, Faruk EA, Hamilton TC, Nash DJ, Stemp G, Willcocks K (1986) J Med Chem 29:2194–2201

    Article  PubMed  CAS  Google Scholar 

  187. Faruk E (1984) Eur pat. Appl. 120,428 (an Beecham)

    Google Scholar 

  188. Block F, Szabo L, Jaspers RM, Heim C, et al. (1993) Levemopamil reduces spatial learning deficit following transient occlusion of common carotid arteries in normotensive rats. Acta Neurol Scand 88:35–40

    Article  PubMed  CAS  Google Scholar 

  189. Gomi S, Greenberg JH, Croul S, Reivich M (1995) Failure of levemopamil to improve histological outcome following temporary occlusion of the middle cerebral artery in cats. J neurol Sci 130:128–133

    Article  PubMed  CAS  Google Scholar 

  190. Drugs Fut (1994) 19(2):111-113

    Google Scholar 

  191. Stokbroekx R, Luyckx M, Willems JA (1981) (Janssen Phamaceutica N.V.) Eur Pat Appl EP 34415 26.8.81; US Appl 114924 24.1.1980; zit. nach CA (1982) 96:19975a

    Google Scholar 

  192. Stokbroekx RA, Luyckx MGM, Willems JJM (1983) (Janssen Pharmaceutica N.V.) U.S. US 4369184 18.1.1983; zit. nach CA (1983) 99:38370c

    Google Scholar 

  193. Dechant KL, Goa KL (1991) Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis. Drugs 41:202–224

    Article  PubMed  CAS  Google Scholar 

  194. Fricke U, Klaus W (1995) Neue Arzneimittel 1994, Wiss Verlagsges. Stuttgart: S 433–434

    Google Scholar 

  195. Noble S, McTavish D (1995) Levocabastine. An update of its pharmacology, clinical efficay and tolerability in the topical treatment of allergic rhinitis and conjunctivitis. Drugs 50:1032–1049

    Article  PubMed  CAS  Google Scholar 

  196. Knight A (1994) The role of levocabastine in the treatment of allergic rhinoconjunctivitis. Brit J Clin Pract 48:139–143

    PubMed  CAS  Google Scholar 

  197. Abelson MB, Weintraub D (1994) Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitis. Eur J Ophthalmol 4:91–101

    PubMed  CAS  Google Scholar 

  198. Bahmer FA, Ruprecht KW (1994) Safety and efficay of topical levocabastine compared with oral terfenadine. Ann Allergy 72:429–434

    PubMed  CAS  Google Scholar 

  199. Desager JP, Horsmans Y (1995) Pharmacokinetic-pharmacodynamic relationship of H1antihistamines. Clin Pharmacokinet 28:419–432

    Article  PubMed  CAS  Google Scholar 

  200. Heykants J, Van Peer A, Van de Velde V (1995) The pharmacokinetic properties of topical levocabastine: a review. Clin Pharmacokinet 29:221–230

    Article  PubMed  CAS  Google Scholar 

  201. Voeffray R, Perlberger J-C, Tenud L (1987) Helv Chim Acta 70:2058–2064

    Article  CAS  Google Scholar 

  202. Carter HE, Bhattacharyya PK (1957) In: Colowick SP, Kaplan NO (Hrsg.) Methods of Enzymology Vol. II, Academic Press, New York, S. 660–662

    Google Scholar 

  203. Fujisawa S, Shimatani K, Yamada H et al. (1989) Nippon Yakurigaku Zasshi 93:305–14

    Article  PubMed  CAS  Google Scholar 

  204. Sahajwalla CG, Helton ED, Purich ED et al. (1995) J Pharm Sci 84:627–33

    Article  PubMed  CAS  Google Scholar 

  205. Beregi Fr Pat M1658 (1963 an Science-Union, Anm. 04.04.61), zit. nach CA (1963) 59:3831 g

    Google Scholar 

  206. Wieduwilt H, Haendel KH, Jassmann E (1974) Ger. (East) 108971 (12.10.74, Appl 172919 16.08.73), zit. nach CA (1975) 83(13):113915j

    Google Scholar 

  207. Beregi L, Hugon P, LeDouarec JC, Schmitt H (1965) USP 3 198 834 (03.08.65, Appl 27.07.64 an Science Union), zit. nach CA (1965) 63:11425

    Google Scholar 

  208. Hayakawa I, Atarashi S, Yokohamas, Imamura M, Sakano KI, Furukawa M (1986) Antimicrob Agents Chemother 29:163–164

    Article  PubMed  CAS  Google Scholar 

  209. Mitscher LA, Sharma PN, Chu DTW, Shen LL, Pernet AG (1987) J Med Chem 30:2283–2286

    Article  PubMed  CAS  Google Scholar 

  210. Rogge MC, Chien SC, Holland ML (1994 bis 1995) Poster from the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy and Other Scientific Meetings

    Google Scholar 

  211. Aavitsland P, Hoiby EA (1996) Treatment of uncomplicated gonorrhea in adults. New guidelines from the working group against gonorrhea. Tidskr Nor Laegeforen 116:1577–1580

    CAS  Google Scholar 

  212. Chien SC, Chow AT, Natarajan J et al. (1997) Absence of age and gender effects on the pharmacokinetics of a single 500-milligram oral dose of levofloxacin in healthy subjects. Antimicrob Agents Chemother 41:1562–1565

    PubMed  CAS  Google Scholar 

  213. Chien SC, Chow AT, Rogge MC et al. (1997) Pharmacokinetics and safety of oral levofloxacin in human immunodeficiency virus-infected individuals receiving concomitant zidovudine. Antimicrob Agents Chemother 41:1765–1769

    PubMed  CAS  Google Scholar 

  214. Chimura T, Arai M, Onuma Y et al. (1997) Concentration of levofloxacin in cervical mucus and its clinical effects on cervicitis. Jap J Antibiot 50:871–877

    CAS  Google Scholar 

  215. Ernst ME, Ernst EJ, Klepser ME (1997) Levofloxacin and trovafloxacin: the next generation of fluoroquinolones? Am J Health Syst Pharm 54:2569–2584

    PubMed  CAS  Google Scholar 

  216. Forster C, Schwabe R, Lozo E et al. (1997) Quinolone-in-duced arthropathy exposure of magnesium-deficient aged rats or immature rats, mineral concentrations in target tissues and pharmacokinetics. Arch Toxicol 72:26–32

    Article  PubMed  CAS  Google Scholar 

  217. Guillemin I, Jarlier V, Cambau E (1998) Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria. Antimicrob Agents Chemother 42:2084–2088

    PubMed  CAS  Google Scholar 

  218. Langtry HD, Lamb HM (1998) Levofloxacin. Its use in infections of the respiratory tract, skin, soft tissues and urinary tract. Drugs 156:487–515

    Article  Google Scholar 

  219. Hoffner SE, Gezelius L, Olsson-Liljequist B (1997) In-vitro activity of fluorinated quinolones and macrolides against drug-resistant Mycobacterium tuberculosis. J Antimicrob Chemother 40:885–888

    Article  PubMed  CAS  Google Scholar 

  220. Ishida H, Ishida Y, Kurosawa Y et al. (1998) In vitro and in vivo activities of levofloxacin against biofilm-producing Pseudomonas aeruginosa. Antimicrob Agents Chemother 42:1641–1645

    PubMed  CAS  Google Scholar 

  221. Jones SF, Smith (1997) Quinolones may induce hepatitis. Brit Med J 314:869

    Article  PubMed  CAS  Google Scholar 

  222. Klein NC, Cunha BA (1998) Treatment of legionnaires’ disease. Semin Respir Infect 13:140–146\

    PubMed  CAS  Google Scholar 

  223. Klimberg IW, Cox CE, Fowler CL et al. (1998) A controlled trial of levofloxacin and lomefloxacin in the treatment of complicated urinary tract infection. Urology 51:610–615

    Article  PubMed  CAS  Google Scholar 

  224. Makinen M, Forbes PD, Stenback F (1997) Quinolone antibacterials: a new class of photochemical carcinogens. J Photochem Photobiol B 37:182–187

    Article  PubMed  CAS  Google Scholar 

  225. Martin SJ, Meyer JM, Chuck R et al. (1998) Levofloxacin and sparfloxacin: new quinolone antibiotics. Ann Pharma-cother 32:320–336

    Article  CAS  Google Scholar 

  226. Maurin M, Raoult D (1997) Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rik-kettsia conorii, „Israeli spotted fever group rickettsia“ and Coxiella burnetii. J Antimicrob Chemother 39:725–730

    Article  PubMed  CAS  Google Scholar 

  227. Mori H, Nakajima T, Nakayama A et al. (1998) Interaction between levofloxacin and vancomycin in rats — study of serum and organ levels. Chemother 44:181–189

    Article  CAS  Google Scholar 

  228. Morrissey I, Hoshino K, Sato K et al. (1996) Mechanism of differential activities of ofloxacin enantiomers. Antimicrob Agents Chemother 40:1775–1784

    PubMed  CAS  Google Scholar 

  229. Nichols RL, Smith JW, Gentry LO et al. (1997) Multicenter, randomized study comparing levofloxacin and ciprofloxacin for uncomplicated skin and skin structure infections. South Med J 90:1193–1200

    Article  PubMed  CAS  Google Scholar 

  230. Nicodemo AC, Robledo JA, Jasovich A et al. (1998) A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections. Int J Clin Pract 52:69–74

    PubMed  CAS  Google Scholar 

  231. Nichterlein T, Bornitz F, Kretschmar M et al. (1998) Successful treatment of murine listeriosis and salmonellosis with levofloxacin. J Chemother 10:313–319

    PubMed  CAS  Google Scholar 

  232. North DS, Fish DN, Redirigton JJ (1998) Levofloxacin, a second-generation fluoroquinolone. Pharmacother 18:915–935

    CAS  Google Scholar 

  233. Piddock LJV, Johnson M, Ricci V et al. (1998) Activities of new fluoroquinolones against fluoroquinolone-resistant pathogens of the lower respiratory tract. Antimicrob Agents Chemother 42:2956–2960

    PubMed  CAS  Google Scholar 

  234. Preston SL, Drusano GL, Berman AL et al. (1998) Levofloxacin population pharmacokinetics and creation of a demographic model for prediction of individual drug clearance in patients with serious community-acquired infection. Antimicrob Agents Chemother 42:1098–1104

    PubMed  CAS  Google Scholar 

  235. Rastogi N, Goh KS, Bryskier A et al. (1996) In vitro activities of levofloxacin used alone and in combination with first-and second-line antituberculous drugs against Mycobacterium tuberculosis. Antimicrob Agents Chemother 40:1610–1616

    PubMed  CAS  Google Scholar 

  236. Richard GA, Klimberg IN, Fowler CL et al. (1998) Levofloxacin versus ciprofloxacin versus lomefloxacin in acute pyelonephritis. Urology 52:51–55

    Article  PubMed  CAS  Google Scholar 

  237. Sieb JP (1998) Fluoroquinolone antibiotic block neuromuscular transmission. Neurol 50:804–807

    Article  CAS  Google Scholar 

  238. Spangler SK, Lin G, Jacobs MR et al. (1998) Postantibiotic effect and postantibiotic sub-MIC effect of levofloxacin compared to those of ofloxacin, ciprofloxacin, erythromycin, azithromycin, and clarithromycin against 20 pneumococci. Antimicrob Agents Chemother 42:1253–1255

    PubMed  CAS  Google Scholar 

  239. Tanaka M, Onodera Y, Uchida Y et al. (1997) Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus. Antimicrob Agents Chemother 41:2362–2366

    PubMed  CAS  Google Scholar 

  240. Umezawa N, Arakane K, Ryu A et al. (1997) Participation of reactive species in phototoxicity induced by quinolone antibacterial agents. Arch Biochem Biophys 342:275–281

    Article  PubMed  CAS  Google Scholar 

  241. Verho M, Malerczyk V, Damm D et al. (1996) Pharmacokinetics of levofloxacin in comparison to the racemic mixture of ofloxacin in man.

    Google Scholar 

  242. Yamakuchi M, Nakata M, Kawahara K et al. (1997) New quinolones, of floxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines. Cancer Lett 119:213–219

    Article  PubMed  CAS  Google Scholar 

  243. Yoshimura T, Kurita C, Usami E et al. (1996) Immunomodulatory action of levofloxacin on cytokine production by human peripheral blood mononuclear cells. Chemother 42:459–464

    Article  CAS  Google Scholar 

  244. Babin D, Fourneron JD, Julia M (1981) Tetrahedron, Suppl. 9:1–7, zit. nach CA 95:169447y

    Article  Google Scholar 

  245. Isaac O, Schneider H, Eggenschwiller H (1968) Dtsch Apoth Ztg 108:293

    CAS  Google Scholar 

  246. O’Brien KG, Penfeld AR, Werner RL (1953) Australien J Chem 6:166–172

    Article  Google Scholar 

  247. Herrmann R (1982) Dtsch Apoth Ztg 122(36): 1797

    CAS  Google Scholar 

  248. Pliva J, Horak M, Herout V, Sorm A, Terpenspektren I, Akad. Verlag Berlin

    Google Scholar 

  249. Mar31, S. 1721

    Google Scholar 

  250. Ueda H, Shibahara Y, Shimizu S (1959) Bl agric chern Soc Japan 23:376–379

    CAS  Google Scholar 

  251. Eccles R, Jones AS (1983) J Laryngol Otol 97:705–709

    Article  PubMed  CAS  Google Scholar 

  252. Eccles R, Griffiths DH, Newton CG, Tolley NS (1988) J Laryngol Otol 102:506–508

    Article  PubMed  CAS  Google Scholar 

  253. Green BG (1985) Physiol Behav 35:427–434

    Article  PubMed  CAS  Google Scholar 

  254. Green BG (1986) Physiol Behav 38:833–838

    Article  PubMed  CAS  Google Scholar 

  255. Eccles R, Morris S, Jawad MS (1990) Clin Otolaryngol 15:39–42

    Article  PubMed  CAS  Google Scholar 

  256. Okabe H, Obata Y, Takayama K, Nagai T (1990) Drug Design Delivery 6:229–238

    CAS  Google Scholar 

  257. Laude EA, Morice AH, Grattan TJ (1994) Pulm Pharmacol 7:179–184

    Article  PubMed  CAS  Google Scholar 

  258. Madyastha KM, Srivatsan V (1988) Drug Metabol Disp 16:765–772

    CAS  Google Scholar 

  259. Rote Liste (1998) EVC-Edition Cantor, Aulendorf/Württ.

    Google Scholar 

  260. Clarke EGC (Hrsg.) Isolation and Identification of Drugs, Bd. 2. (1978) The Pharmaceutical Press, London, S.757

    Google Scholar 

  261. Kuemmerle HP (1989) Klinisch-Pharmakologische Arzneimittelprofile. Levromazin, ecomed

    Google Scholar 

  262. Blazek J, Pinkasova M (1979) Cesk Farm 28;367, zit. nach CA (1980) 93:245578t

    PubMed  CAS  Google Scholar 

  263. Walash MI, Rizk M, Abou-Ouf AM, Belal F (1983) Analyst (London) 108:626–628

    Article  CAS  Google Scholar 

  264. Taha AM, EL-Rabbat NA, EI-Kommos M, Refat IH (1983) Analyst (London) 108:1500–1505

    Article  CAS  Google Scholar 

  265. Szabolcs L (1980) Acta Pharm Hung 50:130–133

    PubMed  CAS  Google Scholar 

  266. Jacob RM, Robert JG (1958) US Pat 2837518, zit. nach CA (1958) 52. 16382d

    Google Scholar 

  267. Rhone-Poulenc (1958) Brit. Pat 789703, zit. nach CA (1959) 53:4312g

    Google Scholar 

  268. Jacob RM, Régnier GR (1958) DB Pat 1040034, zit. nach CA (1961) 55:3626f

    Google Scholar 

  269. Hattori H et al. (1992) J Chromatogr 579:247, zit. nach CA (1992) 117:184187e

    Article  PubMed  CAS  Google Scholar 

  270. Loennenchen T, Dahl SG (1990) J Chromatogr 503:205–215

    Article  Google Scholar 

  271. Kintz P, Lamant JM, Mangin P (1990) Analyst 115:1269-??

    Article  PubMed  CAS  Google Scholar 

  272. Kom, S. 1420

    Google Scholar 

  273. Martin L, Genest K, Cloutier JAR, Farmilo CG (1963) Bull Narcot 15(3–4): 17–38, zit. nach CA (1964) 60:13096g

    CAS  Google Scholar 

  274. Leysen J, Gommeren W, Laduron P (1976) Discrimination of narcotic drugs on 3-fentanyl receptor binding. Arch Int Pharmacodyn Ther 220:335–338

    PubMed  CAS  Google Scholar 

  275. Haikala HO, Honkanen EJ, Lonnberg KK, Nore PT, Pystynen JJ, Luiro AM, Pippuri AK GB 2.228.004 (1990) (an Orion-Yhtyma) CA 114:228967d

    Google Scholar 

  276. Haikala HO, Nore PT, Honkanen EJ, Pystynen JJ, Lonnberg KK, LuiroAM, PippuriAK EP 383.449 (1990) (an Orion-Yhtyma) CA 114:81895t

    Google Scholar 

  277. Pagel PS, Haikala HO, Pentkäinen PJ, Toivonen ML, Nieminen MS, Lehtonen L, Papp JG, Warltier DC (1996) Cardiovasc Drug Rev 14:286–316

    Article  CAS  Google Scholar 

  278. Haikala H, Levijoki J, Linden IB (1995) Troponin C-mediated calcium sensitization by levosimendan accelerates the proportional development of isometric tension. J Mol Cell Cardiol 27:2155–2165

    Article  PubMed  CAS  Google Scholar 

  279. Haikala H, Linden IB (1995) Mechanisms of action of calcium-sensitizing drugs. J Cardiovasc Pharmacol 26(Suppl 1):S10–S19

    PubMed  CAS  Google Scholar 

  280. Haikal H, Nissinen E, Etemadzadeh E, Levijoki J; et al. (1995) Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol 25:794–801

    Article  Google Scholar 

  281. Rump AF, Acar D, Rosen R, Klaus W (1994) Functional and antiischaemic effects of the phosphodiesterase inhibitor levosimendan in isolated rabbit hearts. Pharmacol To-xicol 74:244–248

    Article  CAS  Google Scholar 

  282. Udvary E, Papp JG, Vegh A (1995) Cardiovascular effects of the calcium sensitizer, levosimendan, in heart failure induced by rapid pacing in the presence of aortic constriction. Br J Pharmacol 114:656–661

    Article  PubMed  CAS  Google Scholar 

  283. Lilleberg JM, Sundberg S, Leikola-Pelho N, Nieminen MS (1994) Hemodynamic effects of the novel cardiotonic drug simendan: echocardiographic assessment in healthy volunteers. Cardiovasc Drugs Ther 8:263–269

    Article  PubMed  CAS  Google Scholar 

  284. Sundberg S, Lilleberg J, Nieminen MS, Lehtonen L (1995) Hemodynamic and neurohumoral effects of levosimendan, a new calcium sensitizer, at rest and during exercise in healthy men. Am J Cardiol 75:1061–1066

    Article  PubMed  CAS  Google Scholar 

  285. Antila S, Eha J, Heinpalu M, Lehtonen L, et al. (1996) Haemodynamic interactions of a new calcium sensitizing drug levosimendan and captopril. Eur J Clin Pharmacol 49:451–458

    Article  PubMed  CAS  Google Scholar 

  286. Pagel PS, Hettrick DA, Warltier DC (1996) Comparison of the effects of levosimendan, pimobendan, and milrinone on canine left ventricular-arterial coupling and mechanical efficiency. Basic Res Cardiol 91:296–307

    Article  PubMed  CAS  Google Scholar 

  287. Goldberg BB, Liu JB, Burns N, Meton BA, Forsberg F (1993) Galactose-Based Intravenous Sonographic Contrast Agent: Experimental Studies. Journal of Ultrasound Medicine, 12(8):463–470

    CAS  Google Scholar 

  288. Smith MD, Elion JL, McLure RR, Kwan OL, De Mairia AN (1989) Left Heart Opacification with Peripheral Venous Injections of a New Saccharide Echo Contrast Agent in Dogs. Journal of American College of Cardiology 13(7), 1622–1628

    Article  CAS  Google Scholar 

  289. Schlief R, Schümann R, Niendorf HP (1993) Basic Properties and Results of Clinical Trials of Ultrasound Contrast Agents Based on Galactose. Annals Academy of Medicine 22(5):762–767

    CAS  Google Scholar 

  290. Beckmann S, Schartl M, Bocksch W, Paeprer H (1993) Streßechokardiographie; Beurteilung der links-ventrikulären Funktion nach Gabe des lungengängigen Echokontrastmittels SH U508 A. Z. Kardiol. 82/5:317–323

    Google Scholar 

  291. Völler H, Schröder K, Spielberg C, Uhrig A, Wilkenshoff U, Dissmann R, Schlief R, Schröder R (1993) Does Cardiac Function Modify Left Heart Opacification With Transpulmonary Echo Contrast Agents? Echocardiography 10/1:41–47

    Article  PubMed  Google Scholar 

  292. Bogdan U, Becker G, Schlief R, Reddig J, Hassel W (1993) Contrast-Enhanced Transcranial Color-Coded Real-Time Sonography, Results of a Phase Two Study. Stroke 25:676–684

    Article  Google Scholar 

  293. Sitzer M, Fürst G, Siebler M, Steinmetz H (1994) Usefulness of an Intravenous Contrast Medium in the Characterization of High-Grade Internal Carotid Stenosis With Color-Doppler-Assistend Duplex Imaging Stroke 25/2:385–389

    Google Scholar 

  294. Alien CM, Balen FG, Missouris C, MacGregor G, Bukkingham T, Lees WR (1993) Renal Artery Stenosis: Diagnosis Using Contrast-Enhanced Doppler Ultrasound. Clinical Radiology 48/5:348

    Article  Google Scholar 

  295. Fobbe F, et al. (1992) Farbkodierte Duplexsonographie und Ultraschallkonstrastmittel zur Untersuchung peripherer Arterien — Erste klinische Erfahrungen. Ultraschall in Med. 13:193–198

    Article  CAS  Google Scholar 

  296. Suren A, Osmers R, Kulenkampff D, Kuhn W (1994) Visualization of Blood Flow in Small Ovarian Tumor Vessels by Transvaginal Color Doppler Sonography After Echo Enhancement with Injection of Levovist. Gynecol. Obstet. Invest. 38:210–212

    Article  PubMed  CAS  Google Scholar 

  297. Nanda NC (1993) Echocontrast Enhancers — How Save are They? In: N. Nanda and R. Schlief (Eds.) Advances in Echo Imaging Using Contrast Enhancement. London, Kluwer Academic Publishers, 97–110

    Chapter  Google Scholar 

  298. Xie F, Shapiro J, Meltzer R (1987) Toxicity of Intracoronary Microbubbles in Contrast Echo. Circulation 76(4):505

    Google Scholar 

  299. Dick CD, Feinstein SR, Peterson EM, et al. (1987) Biodistribution of Transpulmonary Echocardiographic Contrast Agent. Circulation, 76(4):506

    Google Scholar 

  300. Fritzsch TH, Maaß B, Müller B, et al. (1991) Composition and Tolerance of Galactose-Based Echo Contrast Media. In: H. Katayama and R.C. Brash (eds). New Dimensions of Contrast Media. Tokyo: Excerpta Medica International Congress Series 976:156–162

    Google Scholar 

  301. Schlief R, Schürmann R, Balzer T, et al. (1993) Saccharide Based Contrast Agents. In: N. Nanda and R. Schlief (eds.) Advances in Echo Imaging using Contrast Enhancement. London, Kluwer Academic Publishers, 71–96

    Chapter  Google Scholar 

  302. Marchesini G, Fabbri A, Bugianesi E, et al. (1990) Analysis of the Deterioration Rates of Liver Function in Cirrhosis, Based on Galactose Elimination Capacity. Liver 10(2):65–71

    PubMed  CAS  Google Scholar 

  303. Vink CLJ (1959) The Half-Life Concept in the Determination of the Functional Capacity of the Liver. Clinica Chimica Acta 4(4):583–589

    Article  CAS  Google Scholar 

  304. Gril H, Reiter F, Löser R, Schliack M, Seibel K (Klinge Pharma GmbH) DE 3326164, EP 133935, US 4582857, zit. nach (1995) Drugs Fut 20:352-355

    Google Scholar 

  305. Hasibeder H, Staab HJ, Seibel K, Heibel B, Schmidle G, Marz W (1991) Clinical phamacology of the hypocholesterolemic agent K12.148 (lifibrol) in healthy volunteers. Eur J Clin Pharmacol 40 Suppl 1:S91–94

    Article  PubMed  CAS  Google Scholar 

  306. Locker PK, Jungbluth GL, Francom SF, Hughes GS Jr (1995) Lifibrol: a novel lipid lowering drug for the therapy of hypercholesterolemia. Lifibrol Study Group. Clin Pharmacol ther 57:73–88

    Article  PubMed  CAS  Google Scholar 

  307. Schwandt P, Elsasser R, Schmidt C, Gertz B, Heil M, Augustin J, Seibel K (1994) Safety and efficacy of lifibrol upon four-week administration to patients with primary hypercholesterolaemia. Eur J Clin Pharmacol 47:133–138

    Article  PubMed  CAS  Google Scholar 

  308. Krause BR, Bousley R, Kieft K, Robertson D, Stansfield R, Urda E, Newton RS (1994) Comparison of lifibrol to other lipid-regulating agents in experimental animals. Pharmacol Res 29:345–357

    Article  PubMed  CAS  Google Scholar 

  309. The Aldridge Library of NMR Spektra (1983) Aldridge Chemical Company

    Google Scholar 

  310. Formaček V, Kubeczeka KH (1979) Einsatzmöglichkeiten der 13C-NMR-Spektroskopie bei der Analyse ätherischer Öle. In: Kubeczka KH (Hrsg.) Vorkommen und Analytik ätherischer Öle, Georg Thieme Verlag, Stuttgart

    Google Scholar 

  311. Ruzicka L, Fornasir V (1919) Helv Chim Acta 2:182

    Article  CAS  Google Scholar 

  312. Young, Webb (1951) Am Soc 73:780, zit. nach BeillV, Bd.2/1, S.205

    Article  CAS  Google Scholar 

  313. Eastman Kodack Co (1952) U.S.P. 2794826, zit. nach Beil IV, Bd.2/1, S.205

    Google Scholar 

  314. Hoffmann-La Roche U.S.P. 2797235, zit. nach Beil IV, Bd. 2/1, S. 205

    Google Scholar 

  315. Beil IV, Bd. 2, S. 205

    Google Scholar 

  316. Mar 30, S. 1368

    Google Scholar 

  317. Mar 30, S. 1383

    Google Scholar 

  318. Lamas JA, Selyanko AA, Brown DA (1997) Eur J Neurosci 9:605–16

    Article  PubMed  CAS  Google Scholar 

  319. Pieniaszek HJ, Fiske WD, Saxton TD et al. (1995) J Clin Pharmacol 35:22–30

    Article  PubMed  CAS  Google Scholar 

  320. Rockwood K, Beattle BL, Eastwood MR et al. (1997) Can J Neurol Sci 24:140–45

    PubMed  CAS  Google Scholar 

  321. Selavka CM, Krull IS (1987) Anal Chem 59:2699–2703

    Article  PubMed  CAS  Google Scholar 

  322. Rapaka RS, Roth J, Prasad VK (1982) J Chromatogr 236:496–498

    Article  CAS  Google Scholar 

  323. Jacobsen E, Fonahn E (1980) Anal Chim Acta 119:33–38, zit. nach CA (1981) 94:7817

    Article  CAS  Google Scholar 

  324. Vandeputte M, Dryon L, De Hertogh L, Mssart DL (1979) J Pharm Sci 68:1416–1418

    Article  PubMed  CAS  Google Scholar 

  325. Graham JH, Banes D, Biesemeyer ME, Nadkarni A (1974) J Pharm Sci 63:763–766

    Article  PubMed  CAS  Google Scholar 

  326. Bauer RJ (1990) Lithium and Lithium Compounds. In: Elvers B, Hawkins S, Schulz G (Hrsg.) Ullmann’s Encyclopedia of Industrial Chemistry, 5. Aufl., Bd. A15, VCH Verlagsgesellschaft, Weinheim, S. 407 f

    Google Scholar 

  327. Hag, Bd. V, S.537 f

    Google Scholar 

  328. Stober HC (1986) Lithium Carbonate. In: Florey K (Hrsg.) Analytical Profiles of Drug Substances, Bd. 15, Academic Press, New York, S. 367 ff

    Chapter  Google Scholar 

  329. Lehmann K (1986) Pharmakokinetik. In: Müller-Oerlinghausen B, Greil W (Hrsg.) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin: 106–115.

    Chapter  Google Scholar 

  330. Shelley RK, Davidson R, Silverstone T (1986) IR CS Med Sci 14:1143–1144

    CAS  Google Scholar 

  331. Gmelin’s Handbuch der Anorganischen Chemie (1927) Lithium, System-Nr. 20, 8. Aufl., Verlag Chemie, Berlin, S.125 f

    Google Scholar 

  332. Bauer RJ (1990) Lithium and Lithium Compounds. In: Elvers B, Hawkins S, Schulz G (Hrsg.) Ullmann’s Encyclopedia of Industrial Chemistry, 5. Aufl., Bd. A15, VCH Verlagsgesellschaft, Weinheim, S. 408

    Google Scholar 

  333. Stoltzenburg MC, Greil W (1986) Behandlung der Manie mit Lithiumsalzen. In: Müller-Oerlinghausen B, Greil W (Hrsg.) die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin: S116–129

    Chapter  Google Scholar 

  334. Goodwin FK, Zia A (1979) Arch Gen Psychiatry 36:840–844

    Article  PubMed  CAS  Google Scholar 

  335. Schou M (1978) Lithium for affective disorders: cost and benefit. In: Ayd FJ, Taylor IJ (eds.) Mood disorders: the world’s major public health problem. Ayd Medical Communications, Baltimore. pp:117–137

    Google Scholar 

  336. Greil W, Schölderle M (1986) Rezidivprophylaxe affektiver Psychosen mit Lithium. IN: Müller-Oerlinghausen B, Greil W (Hrsg.) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer-Verlag, Berlin: 138–163

    Chapter  Google Scholar 

  337. Wood AJ, Goodwin GM (1987) Psychol Med 17:579–600

    Article  PubMed  CAS  Google Scholar 

  338. Ebstein RP, Hermoni M, Belmaker RH (1980) J Pharmacol Exp Ther 213:161–167

    PubMed  CAS  Google Scholar 

  339. Newman ME, Belmaker RH (1987) Neuropharmacology 26:211–217

    Article  PubMed  CAS  Google Scholar 

  340. Avissar S, Schreiber G, Danon A, Belmaker RH (1988) Nature 331:440–442

    Article  PubMed  CAS  Google Scholar 

  341. Berridge MJ, Irvine RF (1984) Nature 312:315–321

    Article  PubMed  CAS  Google Scholar 

  342. Calker D van, Greil W (1986) Biochemische und zellphysiologische Effekte von Lithiumionen. In: Müller-Oerlinghausen B, Greil W (Hrsg.) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer-Verlag, Berlin:5–34

    Chapter  Google Scholar 

  343. Greil W (1981) Bibl Psychiatr 161:69–103

    PubMed  Google Scholar 

  344. Greil W, Calker D van (1983) Lithium: Grundlagen und Therapie. IN: Langer G, Heimann H (Hrsg.) Psychopharmaka. Grundlagen und Therapie. Springer, Wien: 161–202

    Chapter  Google Scholar 

  345. Lehmann K (1986) Pharmakokinetik. In: Müller-Oerlinghausen B, Greil W (Hrsg.) Die Lithiumtherapie. Nutzen, Risiken, Alternativen. Springer, Berlin: 106–115

    Chapter  Google Scholar 

  346. Shelley RK, Davidson R, Silverstone T (1986) IR CS Med Sci 14:1143–1144

    CAS  Google Scholar 

  347. Möller HJ, Schmauß M (1996) Arzneimitteltherapie in der Psychiatrie. Wissenschaftl. Verlagsgesellschaft, Stuttgart

    Google Scholar 

  348. Franks RD, Dubovsky SL, Lifshitz M, et al. (1982) Arch Gen Psychiatry 39:1074–1077

    Article  PubMed  CAS  Google Scholar 

  349. Mann J, Gershon S (1980) Absolute and relative contraindications to lithium treatment. In: Johnson FN (ed.) Handbook of lithium therapy. MTP Press, Lancaster. pp:265–278

    Chapter  Google Scholar 

  350. Thiels C (1987) Pharmacopsychiatry 20:133–146

    Article  PubMed  CAS  Google Scholar 

  351. Faust V, Baumhauer H (1990) Psychopharmaka. Ecomed, Landsberg

    Google Scholar 

  352. Apte SN, Langston JW (1983) Ann Neurol 13:452–458

    Article  Google Scholar 

  353. Clissold SP (1986) Aspirin and related derivates of salicylic acid. Drugs 32 Suppl 4:8–26

    Article  PubMed  CAS  Google Scholar 

  354. Schou M (1980) Lithiumbehandlung der manisch-depressiven Krankheit. Thieme Verlag, Stuttgart, New York

    Google Scholar 

  355. Bauer RJ (1990) Lithium and Lithium Compounds. In: Elvers B, Hawkins S, Schulz G (Hrsg.) Ullmann’s Encyclopedia of Industrial Chemistry, 5. Aufl., Bd.A15, VCH Verlagsgesellschaft, Weinheim, S. 410

    Google Scholar 

  356. Moffat AC, Jackson-JV, Moss MS, Widdop B (Hrsg.). (1986) Clarke’s Isolation amd Identification of Drugs, 2. Aufl., The Pharmaceutical Press, London

    Google Scholar 

  357. Schmidt F (1974) Dtsch Apoth Ztg 114:1593–1597

    CAS  Google Scholar 

  358. Sloan JW, Todd GD, Martin WR (1984) Nature of nicotine bindung to rat brain P2 fraction, Pharmacol Biochem Behav 20:899–909

    Article  PubMed  CAS  Google Scholar 

  359. Lee K, Miwa S, Koshimura K, Ito A (1992) Characterization of nicotinic acetylcholine receptors on cultured bovine adrenal chromaffine cells using modified L-[3H]nicotine binding assay, Naunyn Schmiedeberg’s Arch Pharmacol 345:363–369

    Article  CAS  Google Scholar 

  360. Libri V, Das B, Constanti A (1992) Ganglionic nicotinic receptor agonists exhibit antimuscarinic effects in guineapig olfactory cortical brain slices, Eur J Pharmacol 212:253–258

    Article  PubMed  CAS  Google Scholar 

  361. Bhat RV, Turner SL, Selvaag SR, Marks MJ, Collins AC (1991) Regulation of brain nicotinic receptors by chronic agonist infusion, J Neurochem 56:1932–1939

    Article  PubMed  CAS  Google Scholar 

  362. Reavill C, Walther B, Stolerman IP, Testa B (1990) Behavioral and pharmacokinetic studies on nicotine, cytisine and lobeline, Neuropharmacology 29:619–624

    Article  PubMed  CAS  Google Scholar 

  363. Prabhakar NR, Mitra J, Overholt JC, Cherniak NS (1986) Analysis of postinspiratory activity of phrenic motoneurons with chemical and vagal reflexes, J Appl Physiol 61:1499–1509

    PubMed  CAS  Google Scholar 

  364. Martin WR, Kumar S, Sloan JW (1988) Opioid and nicotinic medullary hyperalgesic influences in the decerebrated rat, Pharmacol Biochem Behav 29:725–731

    Article  PubMed  CAS  Google Scholar 

  365. Steffen R (1984) Was läßt sich über die Wirksamkeit verschiedener Methoden zur Raucherentwöhnung aussagen? Schweiz Rundschau Med Praxis 73:1295–1297

    CAS  Google Scholar 

  366. Kim HL (1985) Effects of SKF 525-A, phenobarbital and 3-methylcholanthrene on the toxicity of lobeline sulfate, Vet Hum Toxicol 27:1–2

    PubMed  CAS  Google Scholar 

  367. Brown NM, Trizna Z, Pathak S (1992) Clastogenic interactions between lobeline sulfate and ethyl alcohol: a cytogenic study, Anticancer Res 12:1467–1469

    PubMed  CAS  Google Scholar 

  368. Klein M, Canoll PD, Musacchio JM (1991) SKF 525-A and cytochrome P-450 ligands inhibit with high affinity the binding of [3H]dextromethorphan and σ-ligands to guinea-pig brain, Life Sci 48:543–550

    Article  PubMed  CAS  Google Scholar 

  369. Mar31, S. 1444

    Google Scholar 

  370. Lancaster SG, Gonzalez JP (1989) Drugs 37:123–140

    Article  PubMed  CAS  Google Scholar 

  371. Reid F, Henry JA (1990) Pharmacopsychiatry 23 Suppl. 1:23–27

    Article  PubMed  Google Scholar 

  372. Shopsin B, Cassano GB, Conti L (1981) An Overview of New „Second Generation“ Antidepressant Compounds: Research and Treatment Implications. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, Behavioral, and Clinical Perspectives. Raven Press, New York, S. 219–251

    Google Scholar 

  373. Leonard BE (1987) Int Clin Psychopharmacol 2:281–297

    Article  PubMed  CAS  Google Scholar 

  374. Sulser F (1983) J Clin Psychiatry 44:14–20

    PubMed  CAS  Google Scholar 

  375. Vetulani J, Sulser F (1975) Nature 257:495–496

    Article  PubMed  CAS  Google Scholar 

  376. Mobley PL, Sulser F (1981) Down-Regulation of the Central Noradrenergic Receptor System by Antidepressant Therapies: Biochemical and Clinical Aspects. In: Enna SJ, Malick JB, Richelson E (Hrsg.) Antidepressants: Neurochemical, Behavioral, and Clinical Perspectives. Raven Press, New York, S. 31–51

    Google Scholar 

  377. Haase AF, Greiner HE, Seyfried CA (1987) Wirkung von Lofepramin in biochemischen Modellen zur Erfassung antidepressiver Effekte. In: Psychiatrische Universitätsklinik Basel (Hrsg.) Neue therapeutische Ansätze in der Pharmakopsychiatrie. Friedr. Vieweg Sohn Verlagsgesellschaft mbH, Braunschweig, S. 19–28

    Google Scholar 

  378. Kopanski C, Turck M, Schultz JE (1983) Neurochem Int 5:649–659

    Article  PubMed  CAS  Google Scholar 

  379. Ghose K, Spragg BP (1989) Int Clin Psychopharmacol 4:201–215

    Article  PubMed  CAS  Google Scholar 

  380. Plym Forshell G, Siwers B, Tuck JR (1976) Eur J Clin Pharmacol 9:291–298

    Article  CAS  Google Scholar 

  381. Stern H, Konetschny J, Herrmann L, Sawe U, Belz GG (1985) Pharmacopsychiatry 18:272–277

    Article  PubMed  CAS  Google Scholar 

  382. Borga O, Azarnoff DL, Plym Forshell G, Sjoqvist F (1969) Biochem Pharmacol 18:2135–2143

    Article  PubMed  CAS  Google Scholar 

  383. Plym Forshell G (1977) Xenobiotica 7:153–163

    Article  Google Scholar 

  384. Baldessarini RJ (1990) Drugs and the Treatment of Psychiatric Disorders. In: Gilman AG, Rall TW, Nies AS, Taylor P (Hrsg.) Goodman and Gilman’s The Pharmacological Basis of Therapeutics. Pergamon Press, New York, S. 383–435

    Google Scholar 

  385. Sieberns S (1985) Therapiewoche 35:5804–5815

    Google Scholar 

  386. Bundesverband der Pharmazeutischen Industrie e.V. (Hrsg.) (1993) Rote Liste 1993, Editio Cantor, Aulendorf/Württ.

    Google Scholar 

  387. Jones GH, Young JM, Venuti MC; EP 107,512 (1986) Drugs Fut 11(1):34-35

    Google Scholar 

  388. Blatt DG (1992) 5-Lipoxygenase inhibitors and their antiinflammatory activities, Prog Med Chem 29, 1–63

    Article  Google Scholar 

  389. Jones GH, Venuti MC, Young JM, Murthy DV, Loe BE, Simpson RA, Berks AH, Spires DA, Maloney PJ, Kruseman M (1986) Topical nonsteroidal antipsoriatic agents. 1. 1,2,3,4-tetraoxygenated naphthalene derivates, J Med Chm 29, 1504–1511

    Article  CAS  Google Scholar 

  390. Black AK, Camp RD, Mallet AI, Cunningham FM, Hofbauer M, Greaves MW (1990) Pharmacologic and clinical effects of lonapalene (RS 43 179), a 5-lipoxygenase inhibitor, in psoriasis, J Invest Dermatol 95, 50–54

    Article  PubMed  CAS  Google Scholar 

  391. Lassus A, Forsstrom S (1985) A dimethoxynaphthalene derivate (RS 43 179) compared with 0.025 % fluocinolone acetonide gel in the treatment of psoriasis, Brit J Dermatol 113, 103–106

    Article  CAS  Google Scholar 

  392. Bosman B (1994) Testing of lipoxygenese inhibitors, cyclooxygenase inhibitors, drugs with immunomodulating properties, and some reference antipsoriatic drugs in the modified mouse tail test, an animal model of psoriasis, Skin Pharmacol 7, 324–334

    Article  PubMed  CAS  Google Scholar 

  393. Brain SD, Camp RDR, Dowd PM, Kobza Black A, Woolard PM, Mallet AI, Greaves MW (1982) Psoriasis and leukotriene B4, Lancet II:762–763

    Article  Google Scholar 

  394. Brain SD, Camp RDR, Cunningham FM, Dowd PM, Greaves MW, Kobza Black A (1984) Leukotriene B4- like material in scale of psoriatic lesions, Brit J Pharmacol 83, 313–317

    Article  CAS  Google Scholar 

  395. Lehmann PA, Tomlinson RV, Johnson JI, Olerud JE, Alkers WA, Franz TJ (1992) Percutaneous absorption and metabolism of lonapalene in psoriatic skin, Pharm Res 9, 1145–1151

    Article  Google Scholar 

  396. Kiang CH, Lee C (1991) High performance liquid Chromatographic determination of the 1-4-diketo-and 1-4-di-keto-2,3-dihydroxy-metabolites of lonapalene in rat urine, J Chromatogr 565, 339–347

    Article  PubMed  CAS  Google Scholar 

  397. Corsi G, Palazzo G (1976) J Med Chem 19:778–783

    Article  PubMed  CAS  Google Scholar 

  398. Putzolu S, Taddeyi (1989) New perspectives in anticancer therapy: a review on lonidamine. Drugs Today 25:195

    Google Scholar 

  399. Hirata T, Hashimoto Y, Ogasa T, Kobayashi S, Matsukuma I, Kimura K, Yoshiie S, Sato K, Ohasi Y, Takasawa S (Kyowa Hakko Kogyo Co., Ltd.) EP 14476; zit. nach Drags Fut (1988) 13:522-525

    Google Scholar 

  400. Matsukuma I, Yoshiye S, Mochida K, Hashimoto Y, Sato K, Okachi R, Hirata T (1989) Chem Pharm Bull 37:1239–1244

    Article  PubMed  CAS  Google Scholar 

  401. Bodurow CC, Boyer BD, Brennan J, Bunnell CA et al. (1989) Tetrahedron Lett 30:2321–2324

    Article  CAS  Google Scholar 

  402. Pasini CE, Indelicato JM (1992) Pharmaceut Res 9:250; zit nach Drugs Fut (1992) 17:523-524

    Google Scholar 

  403. Fachinformation, Lilly Deutschland GmbH, 5387 Giessen

    Google Scholar 

  404. Kovach PM, Lantz RJ, Brier G (1991) J Chrom Biomed Appl 567:129–139

    Article  CAS  Google Scholar 

  405. Skibic MJ, Taylor KW, Occolowitz JL, Collins MW, Paschal JW, Lorenz LJ, Spangle LA, Dorman DE, Baertschi SW (1993) J Pharm Sci 82:1010–1017

    Article  PubMed  CAS  Google Scholar 

  406. Jorgensen JH, Redding JS, Maher LA (1988) Influence of storage and susceptibility test conditions on stability and activity of LY 163 892 and four other cephalosporins. Antimicrob Agents Chemother 32:1477–1480

    Article  PubMed  CAS  Google Scholar 

  407. Cao C, Chin NX, Neu HC (1988) In vitro activity and betalactamase stability of LY 163 892. J Antimicrob Chemother 22:155–165

    Article  PubMed  CAS  Google Scholar 

  408. Howard AJ, Dunkin KT (1988) Comparative in vitro activity of a new carbacephem LY 163 892. J Antimicrob Chemother 22:445–456

    Article  PubMed  CAS  Google Scholar 

  409. Jones RN, Barry AL (1988) Antimicrob activity of LY 163 892, an orally administered 1-carbacephem. J Antimicrob Chemother 22:315–320

    Article  PubMed  CAS  Google Scholar 

  410. Knapp CC, Washington JA (1988) In vitro activities of LY 163 892, cefaclor, and cefuroxime. Antimicrob Agents Chemother 32:131–133

    Article  PubMed  CAS  Google Scholar 

  411. Pelosi E, Fontana R (1988) In vitro activity and beta-lactamase stability of LY 163 892. Eur J Clin Microbiol Infect Dis 8:549–551

    Article  Google Scholar 

  412. Shelton S, Nelson JD (1988) In vitro susceptibilities of common pediatric pathogens to LY 163 892. Antimicrob Agents Chemother 32:268–270

    Article  PubMed  CAS  Google Scholar 

  413. Bauernfeind A, Jungwirth R (1991) Antibacterial activity of cefpodoxime in comparison with cefixime, cefdinir, cefetamet, ceftibuten, loracarbef, cefprozil, BAY-3522, cefuroxime, cefaclor and cefadroxil. Infection 19:353–362

    Article  PubMed  CAS  Google Scholar 

  414. Nelson JD, Shelton S, Kusmiesz H (1988) Pharmacokinetics of LY 163 892 in infants and children. Antimicrob Agents Chemother 32:1738–1739

    Article  PubMed  CAS  Google Scholar 

  415. De Sante KA, Zeckel ML (1992) Pharmacokinetic profile of loracarbef. Amer J Med 92(Suppl. 6A): 16S–19S

    Google Scholar 

  416. Roller S, Lode H, Stelzer I, Deppermann KM, Boeckh M, Koeppe P (1992) Pharmacokinetics of loracarbef and interaction with acetylcysteine. Eur J Clin Microbiol Infect Dis 11:851–855

    Article  PubMed  CAS  Google Scholar 

  417. Dere WH, Farlow D, Therasse DG, Ruoff GE (1992) Loracarbef (LY 163 892) versus cefaclor in the treatment of acute bacterial bronchitis. Clin Ther 14:41–53

    PubMed  CAS  Google Scholar 

  418. Foshee WS (1992) Loracarbef (LY 163 892) versus amoxicillin-clavulanate in the treatment of bacterial acute otiitis media with effusion. J Pediatrics 120:980–986

    Article  CAS  Google Scholar 

  419. Sydnor Jr. TA, Scheid WM, Gwaltney J, Nielsen RW, Huck W, Therasse DG (1992) Loracarbef (LY 163 892) versus amoxicillin/clavulanate in bacterial maxillary sinusitis. Ear, Nose, Throat Journal 71:225–232

    PubMed  Google Scholar 

  420. Hyslop DL, Jacobson K, Guerra FJ (1992) Loracarbef (LY 163 892) versus amoxicillin/clavulanate in bronchopneumonia and lobar pneumonia. Clin Ther 14:254–267

    PubMed  CAS  Google Scholar 

  421. Müller O, Spirer Z, Wettich K (1992) Loracarbef versus penicillin V in the treatment of streptococcal pharyngitis and tonsillitis. Infection 20:301–308

    Article  PubMed  Google Scholar 

  422. Therasse DG (1992) The safety profile of loracarbef: clinical trials in respiratory, skin, and urinary tract infections. Amer J Med 92(Suppl. 6A): 20S–25S

    Article  PubMed  CAS  Google Scholar 

  423. Hyslop DL (1992) Loracarbef (LY 163 892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritis. Amer J Med 92(Suppl. 6A):86S–94S

    Article  PubMed  CAS  Google Scholar 

  424. Daten der Firma Eli Lilly (siehe Fachinformation zu LoribidR)

    Google Scholar 

  425. Drugs Fut (1992) 17(8):683686

    Google Scholar 

  426. Pfister R, Zeller P, Binder D, Hromatka O (Hoffmann-La Roche & Co. AG) DE 2,838,851

    Google Scholar 

  427. Drugs Stab (1996) 1(3): 166-172

    Google Scholar 

  428. Drugs Stab (1997) 1(4):202-208

    Google Scholar 

  429. Bareggi SR, Gambaro V, Valenti M, Benvenuti C (1997) Arzneim Forsch 47(6):755–757

    CAS  Google Scholar 

  430. Suwa T, Urano H, Shinohara Y, Kokatsu J (1993) J Chromatogr, Biomed Appl 617(1): 105–110

    Article  CAS  Google Scholar 

  431. Ankier SI et al. (1988) Postgrad Med J 64:752–754

    Article  PubMed  CAS  Google Scholar 

  432. Tsai RS et al. (1993) Helv Chim Acta 76:842–854

    Article  CAS  Google Scholar 

  433. Pruss TP, Stroissnig H, Radhofer-Weite S, et al. (1990) Overview of the pharmacological properties, pharmacokinetics and anomal safety assessment of lornoxicam. Postgrad Med J, 66 Suppl 4:18–21

    Google Scholar 

  434. McCormack K (1994) Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 1994 59:9–43

    CAS  Google Scholar 

  435. Norholt SE, Sindet-Pedersen S, Bugge C, Brandebjerg PE, Ersboll BK, Bastian HL (1995) A randomized, double blind, placebo-controlled, dose-response study of the analgesic effect of lornoxicam after surgical removal of mandibular third molars. J Clin Phrmacol 35:606–614

    Article  CAS  Google Scholar 

  436. Balfour J, Fitton A, Barradell LB (1996) Lornoxicam: A review of its pharmacology and therapeutic potential in the managment of painful and inflammatory conditions. Drugs 51:639–657

    Article  PubMed  CAS  Google Scholar 

  437. Dittrich P, Radhofer-Weite S, Magometschnigg D, et al. (1990) The effect of concomitantly administered antiacids on the bioavailability of lornoxicam, a novel highly potent NSAID. Drugs Exp Clin Res 16:57–62

    PubMed  CAS  Google Scholar 

  438. Mayerhofer S, Weite S, Magometschnigg D, et al. (1989) The effect of food on pharmacokinetic parameters of the new NSAID lornoxicam in healthy volunteers. 3rd Interscience World conference on Inflammation, Antirheumatics, Analgesics and Immunomodulators, Monte Carlo, 223

    Google Scholar 

  439. Albengres E, Urien S, Barre J, et al. (1993) Clinical pharmacology of oxicams: new insights into the mechanism of their dose-dependent toxicity. Int J Tissue React 15:125–134

    PubMed  CAS  Google Scholar 

  440. Ankier SI, Brimelow AE, Crome P, et al. (1988) Chlortenoxicam pharmacokinetics in young and elderly human volunteers. Postgrad Med J 46:752–754

    Article  Google Scholar 

  441. Hitzenberger G, Radhofer-Weite S, Takacs F et al. (1990) Pharmacokinetics of lornoxicam in man. Postgrad Med J 66 Suppl 4:2–6

    Google Scholar 

  442. Olkkola KT, Brunetto AV, Mattila MJ (1994) Pharmacokinetics of oxicam nonsteroidal anti-inflammatory agents. Clin Pharamcokinet 26(2): 107–120

    Article  CAS  Google Scholar 

  443. Berry H, Bird HA, Black C, et al. (1992) A double blind, multicenter, placebo controlled trail of lornoxicam in patients with osteoarthritis of the hip and knee. Ann Rheum Dis 51:238–242

    Article  PubMed  CAS  Google Scholar 

  444. Caruso I, Montrone F, Boari L, et al. (1994) Lornoxicam versus diclofenac in rheumatoid arthritis: a double blind, multicenter study. Adv Ther 11:132–138

    Google Scholar 

  445. Bernstein RM, Fenzel W (1995) A comparative study of two dosage regiments of lornoxicam and standard dosage of naproxen in patients with rheumatoid arthritis. Eur J Clin Res 7:259–273

    Google Scholar 

  446. Bernstein RM, Calin HJ, Calin A (1992) A comparison of the efficacy and tolerability of lornoxicam and indometacin in ankylosing spondylitis. Eur J Rheumatol Inflamm 12:6–13

    Google Scholar 

  447. Rainer F, Klein G, Mayerhofer F, et al. (1996) A prospective, multicenter, operable, uncontrolled Phase II study of the local tolerability, safety and efficacy of intramuscular chlortenoxicam in patients with acute low back pain. Eur J Clin Res 8:1–13

    Google Scholar 

  448. Sternieri E, Bussone G, Manzoni GC, et al. (1991) Lornoxicam, a new nonsteroidal anti-inflammatory drug, in migraine prophylaxis: a double-blind multicenter study. Cephalalgia 11 Suppl 11:154–155

    Google Scholar 

  449. Berry H, Ollier S, Lornoxicam Group (1990) Lornoxicam in clinical practice. Postgrad Med J 66 Suppl 4:41–45

    Google Scholar 

  450. Patel A, Skelly AM, Kohn H, et al. (1991) Double-blind placebo-controlled comparison of the analgesic effects of single doses of lornoxicam and aspirin in patients with postoperative dental pain. Br Dent J 170:295–299

    Article  PubMed  CAS  Google Scholar 

  451. Ankier SI, Brimelow AE, Crome P, et al. (1988) Chlortenoxciam pharmacokinetics in young and elderly human volunteers. Postgrad Med J 64:752–754

    Article  PubMed  CAS  Google Scholar 

  452. Turner P, Johnson A (1990) Clinical pharmacokinetic studies with lornoxicam. Postgrad Med J 66 Suppl 4:28–29

    Google Scholar 

  453. Warrington SJ, Lewis Y, Dawnay A, Johnson A, Kovacs IB, Lamb E, Ravic M (1990) Renal and gastrointestinal tolerability of lornoxicam and effects on haemostasis and hepatic microsomal oxidation. Postgrad Med J 66 Suppl 4:35–40

    Google Scholar 

  454. Aabakkeen I, Sones M, Frenzel W (1996) Gastrointestinal tolerability of lornoxicam compared to that of naproxen in healthy male volunteers. Aliment Pharmacol Ther 10:151–156

    Article  Google Scholar 

  455. Ravic M, Salas-Herrera I, Johnson A, et al. (1993) A pharmacokinetic interaction between cimetidin or ranitidine and lomoxicam. Postgrad Med J 69:865–866

    Article  PubMed  CAS  Google Scholar 

  456. Ravic M, Salas-Herrera I, Johnson A, et al (1993) Influence of lornoxicam a new non-steroidal anti-inflammatory drug on lithium pharmacokinetics. Hum Psychpharm 8:289–292

    Article  CAS  Google Scholar 

  457. Hitoglou-Makedou A, Lawson M, Rzurner P, et al. (1989) Comparison of chlortenoxicam and indomethacin on furosemide-induced diuresis. Postgrad med J 65:821–823

    Article  PubMed  CAS  Google Scholar 

  458. Atzpodien E, Mehdi N, Clarke D, Radhofer-Weite S (1997) Subacute and chronic oral toxicity of lornoxieam in cynomoglus monkeys. Food Chem Toxicol, 35(5):465–474

    Article  PubMed  CAS  Google Scholar 

  459. Dunica JV, Carini DJ, Chiu AT, Pierce ME, Price WA, Smith RD, Wells GJ, Wong PC, Wexler RR, Johnson AL, Timmermans PBMWM (1991) Drag Fut 16:305–309

    Google Scholar 

  460. Carini DJ, Dunica JV Eur Pat Appl 253, 310

    Google Scholar 

  461. Carini DJ U.S. pat 5,138,069

    Google Scholar 

  462. Carini DJ, Dunica JV, Aldrich PE, Chiu AT, Johnson AL, Pierce ME, Price WA, Santella III JB, Wells GJ, Wexler RR, Wong PC, Yoo S, Timmermans PBMWM (1991) J Med Chem 34:2525–2547

    Article  PubMed  CAS  Google Scholar 

  463. Datenblatt für Krankenhausapotheker der Firma MSD Sharp & Dohme GmbH

    Google Scholar 

  464. Johnston CI (1990) Biochemistry and Pharmacology of the renin-angiotensin system. Drugs 39:21–31

    Article  PubMed  CAS  Google Scholar 

  465. De Carvalho Frimm C, Sun Y, Weber KT (1997) Angiotension II receptor blockade and myocardial fibrosis of the infarcted rat heart. J Lab Clin Med 129:439–446

    Article  PubMed  Google Scholar 

  466. Himmelmann A, Svensson A, Bergbrant A, Hansson L (1996) Long-term effects of losartan on blood pressure and left ventricular structure in essential hypertension. J Human Hypertension 10:729–734

    CAS  Google Scholar 

  467. Goa KL, Wagstaff AJ (1996) Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Drugs 51:820–845

    Article  PubMed  CAS  Google Scholar 

  468. Velasquez MT (1996) Angiotensin II receptor blockers. A new class of antihypertensive drugs. Archives of Family Medicine 5:351–356

    Article  PubMed  CAS  Google Scholar 

  469. Zhu Z, Arendshorst WJ (1996) Angiotensin II-reeeptor stimulation of cytosolic calcium concentration in cultured renal resistance arterioles. Am J Physiol 271:F1239–F1247

    PubMed  CAS  Google Scholar 

  470. Wilcox CS, Cardozo J, Welch WJ (1996) AT1 and TxA2/ PGH2 receptors maintain hypertension throughout 2K, 1C goldblatt hypertension in the rat. Am J Physiol 271:R891–R896

    PubMed  CAS  Google Scholar 

  471. Devlin AM, Davidson AO, Gordon JF, Campbell AM, Morton JJ, Reid JL, Dominiczak AF (1995) Vascular smooth muscle polyploidy in genetic hypertension: the role of angiotensin II J Human Hypertension 9:497–500

    CAS  Google Scholar 

  472. Grossman E, Peleg E, Caroll J (1994) Hemodynamic and humoral effects of angiotensin II antagonist losartan in essentiell hypertension. Am J Hypertens 7:1041–1044

    PubMed  CAS  Google Scholar 

  473. Gavras HP, Salerno CM (1996) The angiotension II type 1 receptor blocker losartan in clinical practice: a review. Clinical Therapeutics 18:1058–1067

    Article  PubMed  CAS  Google Scholar 

  474. Bynyl RL (1996) Antihypertensive efficacy of the angiotensin II AT1-receptor antagonist losartan: results of a randomized, double-blind, placebo-controlled, parallel-group trial using 24-hour blood pressure monitoring. Ambulatory Blood Pressure Monitoring Study Group. Blood Pressure 2:71–77

    Google Scholar 

  475. Wong YN, Horn KA, Burchham DL, Huang SM, Quon CY (1994) The pharmacokinetics and metabolism of DUP 532, a non-peptide angiotensin II receptor antagonist, in rat and dogs. Biopharmaceutics and Drug Disposition 15:53–63

    Article  CAS  Google Scholar 

  476. Chiu SH (1993) The use of in vitro metabolism studies in the understanding of new drugs. Journal of Pharmacological and Toxicological Methods 29:77–83

    Article  PubMed  CAS  Google Scholar 

  477. Townsend R, Haggert B, Liss C, Edelmann JM (1995) Efficacy and tolerability of losartan versus enalapril alone or in combination with hydrochlorothiazide in patients with essential hypertension. Clinical Therapeutics 17:911–923

    Article  PubMed  CAS  Google Scholar 

  478. Weber M (1997) Clinical safety and tolerability of losartan. Clinical Therapeutics 19:604–616

    Article  PubMed  CAS  Google Scholar 

  479. Goldberg AI, Dunlay MC, Sweet CS (1995) Safety and tolerability of losartan potassium, an angiotensin II antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin converting enzyme inhibitors for the treatment of systemic hypertension. Am J Cardiol 75:793–795

    Article  PubMed  CAS  Google Scholar 

  480. Mitteilung des BfArM, Arzneitelegramm 1998:52

    Google Scholar 

  481. Mar 29, S. 749

    Google Scholar 

  482. Makovec F, Cniste R, Rovati CL, Rovati AL WO 8703869, zit. nach CA (1987) 107:198929

    Google Scholar 

  483. Freidinger RM (1989) Med Res Rev 9:271–290

    Article  PubMed  CAS  Google Scholar 

  484. Niederau C, Heintges T, Rovati L, Strohmeyer G (1989) Gastroenterology 97:1331–1336

    PubMed  CAS  Google Scholar 

  485. Schwarzendrube J, Niderau M, Lüthen R, Niederau C (1991) Gastroenterology 100:1683–1690

    PubMed  CAS  Google Scholar 

  486. Schmidt WE, Schenk S, Nustede R, Rovati LC, Fölsch UR, Creutzfeldt W (1991) Z Gastroenterol 29:502

    Google Scholar 

  487. Meyer BM, Werth BA, Beglinger C (1989) Lancet ii:12–15

    Article  Google Scholar 

  488. Niederau C, Schwarzendrube J, Lüthen R, Niederau M, Strohmeyer G, Rovati L (1991) Pancreas 6:1–10

    Article  Google Scholar 

  489. Drugs Fut (1993) 18(8):704-706

    Google Scholar 

  490. Baader E, Bickel M, Damm D, et al. (1994) Interference in clinical laboratory tests, with special regard to the bilirubin assay: effects of a metabolite of the new prolyl 4-Hydroxylase inhibitor, Lufironil. Eur J Clin Chem Clin Biochem 32:515–520

    PubMed  CAS  Google Scholar 

  491. Bickel M, Baader E, Brocks DG, et al. (1991) Beneficial effects of inhibitors of propyl 4-hydroxylase in CCI 4-induced fibrosis of the liver in rats. J Hepatol 13(Suppl 3):S26–S33

    Article  PubMed  CAS  Google Scholar 

  492. Boker K, Schwarting G, Kaule G, et al. (1991) Fibrosis of the liver in rats induced by bile duct ligation. Effects of inhibition by prolyl 4-hydroxylase. J Hepatol (Suppl 3):S33-40

    Google Scholar 

  493. Horn W (1991) General pharmacology, toxicology and future clinical development of HOE 077. J Hepatol 13(Suppl 3):S63–S65

    Article  PubMed  CAS  Google Scholar 

  494. Kellner HM, Volz M, Baader E, et al. (1991) Pharmacokinetics and metabolism of HOE 077. Preclinical studies. J Hepatol 13(Suppl 3):S48–S61

    Article  PubMed  CAS  Google Scholar 

  495. Matsumura Y, Sakaida I, Uchida K, et al. (1997) Prolyl 4-hydroxylase inhibitor (HOE 077) inhibitis pig serum-induced rat liver fibrosis by preventing stellate cell activation. J Hepatol 27:185–192

    Article  PubMed  CAS  Google Scholar 

  496. Sakaida I, Matsumura Y, Kubota M, et al. (1996) The prolyl 4-hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat fibrosis induced by choline-deficient L-amino acid-defined diet. Hepatology 23:755–763

    PubMed  CAS  Google Scholar 

  497. Sakaida I, Kubota M, Kayano K, et al. (1994) Prevention of fibrosis reduces enzyme-altered lesions in the rat liver. Carcinogenesis 15:2201–2206

    Article  PubMed  CAS  Google Scholar 

  498. Wang YJ, Wang SS, Bickel M, et al. (1998) Two novel antifibrotics, HOE 077 and Safironil, modulate stellate cell activation in rat liver injury: differential effects in males and females. Am J Pathol 152:279–287

    PubMed  CAS  Google Scholar 

  499. Weidenbach H, Lerch MM, Turi S, et al. (1997) Failure of a prolyl 4-hydroxylase inhibitor to alter extracellular matrix deposition during experimental pancreatitis. Digestion 58:50–57

    Article  PubMed  CAS  Google Scholar 

  500. Pharmeuropa (1993) 5:327-330

    Google Scholar 

  501. Römpp, Chemie-Lexikon, (1982) Thieme-Verlag, 9. Aufl.

    Google Scholar 

  502. Hofmann E (1985) Funktionelle Biochemie des Menschen, Bd. 2, Akademie-Verlag Berlin, S. 43

    Google Scholar 

  503. Nuhn P (1990) Naturstoffchemie, Akademie-Verlag Berlin, 2. Aufl., S.422

    Google Scholar 

  504. Auterhoff, Knabe, Höltje (1991) Lehrbuch der Pharmazeutischen Chemie, Wissenschaftliche Verlagsgesellschaft mbH, Stuttgart, 12. Aufl., S.529

    Google Scholar 

  505. Li CH, Simpson ME, Evans HM (1942) J Am Chem 64:376

    Article  Google Scholar 

  506. Takeda K et al. (1952) Proc Jap Acad 28:352, zit. nach CA 47:3383

    Google Scholar 

  507. Otsuka H, Noda Y (1954) J Biochem (Tokyo) 41:547

    CAS  Google Scholar 

  508. Putere M, Berzins-Berzite R, Vina I (1991) LLA Raksti 272:48–54, zit. nach CA 116(22):221398b

    CAS  Google Scholar 

  509. Hiyama J, Surus A, Renwick AGC (1990) J Endocrinol 125(3):493–500

    Article  PubMed  CAS  Google Scholar 

  510. Lu Y, Wang Y (1989) Shengzhi Yu Biyun 9(4): 14–17, zit nach CA 112(21): 192031m

    CAS  Google Scholar 

  511. Greep O et al. (1941) Proc Soc Exp Biol (N Y) 46:644

    CAS  Google Scholar 

  512. Takada K, Itoh M, Nishio H, Ishii S (1989) Zool Sci 6(5):963–974, zit nach CA 112(5):32865h

    CAS  Google Scholar 

  513. Pierce JG, Parson TF (1981) Glycoprotein hormones: structure and function, Ann Rev Biochem 50:465–495

    Article  PubMed  CAS  Google Scholar 

  514. Campbell RK, Dean-Eming DM, Moyle WR (1991) Conversion of human choriongonadotropin into follitropin by protein engeneering, Proc Natl Acad Sci USA 88:760–764

    Article  PubMed  CAS  Google Scholar 

  515. Manzella SM, Dharmesh SM, Berranek MC, Swanson P, Baenzinger JU (1995) Evolutionary conservation of the sulfated oligosaccharides on vertebrate glycoprotein hormones that control circulatory half-life, J Biol Chem 270(37):21665–21671

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Pharmakologie, Freie Universität Berlin, Thielallee 69-73, 14195, Berlin, Deutschland

    Professor Dr. Franz von Bruchhausen

  2. Institut für Pharmazie und Lebensmittelchemie, Universität Würzburg, Am Hubland, 97074, Würzburg, Deutschland

    Professor Dr. Siegfried Ebel & Professor Dr. Ulrike Holzgrabe

  3. Birkenweg 20, 69221, Dossenheim, Deutschland

    Professor Dr. Eberhard Hackenthal

  4. Pharmakologisches Institut, Eberhard-Karls-Universität, Wilhelmstraße 56, 72074, Tübingen, Deutschland

    Priv.-Doz. Dr. Margitta Albinus

  5. Pharmazeutisches Institut, Universität Freiburg, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Apothekerin Gudrun Amschler

  6. Institut für Pharmazie, Universität Regensburg, Universitätsstraße 31, 93040, Regensburg, Deutschland

    Prof. Dr. Erwin von Angerer

  7. Chiron-Behring, Postfach 1630, 35006, Marburg, Deutschland

    Dr. C. Arras-Reiter

  8. Institut für Pharmazie Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität Mainz, Staudinger Weg 5, 55099, Mainz, Deutschland

    Apothekerin Andrea Bauer

  9. An der Steige 18, 73642, Welzheim, Deutschland

    Pia Bauer

  10. Allgemeine Pharmakologie — Abteilung I, Medizinische Hochschule Hannover, 30601, Hannover, Deutschland

    Priv.-Doz. Dr. Winfried Beil

  11. Fachbereich Pharmazie, Ernst-Moritz-Arndt-Universität, Friedrich-Ludwig-Jahn-Straße 17, 17489, Greifswald, Deutschland

    Prof. Dr. Thorsten Beyrich

  12. Kilianstraße 4, 97762, Hammelburg, Deutschland

    Katja Binder

  13. Paracelsusstraße 40, 53757, Sankt Augustin, Deutschland

    Dr. Roswitha Böhme

  14. Institut für Pharmazie, Humboldt-Universität zu Berlin, Goethestraße 54, 13086, Berlin, Deutschland

    Prof. Dr. Hans-Hubertus Borchert

  15. Roßmarkt 14, 97421, Schweinfurt, Deutschland

    Franz Bossle

  16. Institut für Pharmazie, Sophienstraße 10, 80333, München, Deutschland

    Prof. Dr. Franz Bracher

  17. Dorfstraße 31 a, 99510, Hermstedt, Deutschland

    Prof. Dr. Helmut Bräunlich

  18. Zentrum für Vaskuläre Biologie und Medizin, Friedrich-Schiller-Universität Jena, Institut für Experimentelle Angiologie und Hämostaseologie, Nordhäuser Straße 78, 99089, Erfurt, Deutschland

    Dr. Ellen Bretschneider

  19. AG Vitamine/Atherosklerose, Deutsches Institut für Ernährungsforschung, Potsdam-Rehbrücke Arthur Scheunert-Allee 114-116, 14558, Bergholz-Rehbrücke, Deutschland

    Dr. Regina Brigelius-Flohé

  20. In der Ebene 11, 97218, Gerbrunn, Deutschland

    Kerstin Brinkmann

  21. Institut für Pharmazeutische Chemie, Martin-Luther-Universität, Weinbergweg 15, 06120, Halle, Deutschland

    Prof. Dr. Axel Büge

  22. Bundesinstitut für Arzneimittel und Medizinprodukte, Seestraße 10, 13353, Berlin, Deutschland

    Prof. Dr. Wolfram Christ

  23. Lange Rötterstraße 26, 68167, Mannheim, Deutschland

    Monika Cimbollek

  24. Institut für Pharmazie, Universität Regensburg, Universitätsstraße 31, 93053, Regensburg, Deutschland

    Dr. Rolf Daniels

  25. Institut für Pharmazie Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität, Staudinger Weg 5, 55099, Mainz, Deutschland

    Prof. Dr. Gerd Dannhardt

  26. Institut für Pharmazie Abteilung Pharmazeutische Chemie, Universität Hamburg, Bundesstraße 45, 20146, Hamburg, Deutschland

    Prof. Dr. Hans-Jürgen Duchstein

  27. Institut für Pharmazie, Universität Leipzig, Brüderstraße 34, 04103, Leipzig, Deutschland

    Prof. Dr. Kurt Eger

  28. Heidelberger Straße 29, 64342, Seeheim, Deutschland

    Dr. Petra Eichhorn

  29. Pharmazeutisches Institut, Universität Bonn, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Dipl.-Chem. Michael Engler

  30. Pharmaziezentrum der Universität Wien, Althanstraße 14, 1090, Wien, Deutschland

    Dr. Thomas Erker

  31. Am Hang 5, 17498, Riemersort, Deutschland

    Prof. Dr. Peter Felfe

  32. Frankenstraße 17, 63128, Dietzenbach, Deutschland

    Dr. Alfred Fenyves

  33. Sankyo Pharma GmbH, Zielstattstraße 9, 81379, München, Deutschland

    Dr. Reinhard Fescharek (Leiter der Arzneimittelsicherheit)

  34. Pharmazeutisches Institut, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Carmen Frackenpohl

  35. Lehrstuhl für Pharmazeutische Chemie, Universität Freiburg, Pharmazeutisches Institut, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Prof. Dr. August Wilhelm Frahm

  36. Behringwerke AG, 35001, Marburg, Deutschland

    Dr. Volker Franke

  37. Balneopharm Cordes & Co., 30826, Garbsen, Deutschland

    Ulrich Franken

  38. Abteilung für Pharmazeutische Chemie, Institut für Pharmazie, Bundesstraße 45, 20146, Hamburg, Deutschland

    Prof. Dr. Detlef Geffken

  39. Winterleitenweg 61 a, 97082, Würzburg, Deutschland

    Apotheker Uli Geis

  40. Institut für Experimentelle Angiologie und Hämostaseologie Zentrum für Vaskuläre Biologie und Medizin, Klinikum der Friedrich-Schiller-Universität Jena, Nordhäuser Straße 78, 99089, Erfurt, Deutschland

    Prof. Dr. Erika Glusa

  41. Institut für Pharmazie, Humboldt-Universität zu Berlin, Goethestraße 54, 13086, Berlin, Deutschland

    Prof. Dr. Berthold Göber

  42. Pharmazeutisches Institut, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Peter Ndive Gobina

  43. Fachbereich Humanmedizin, Radiologische Klinik u. Poliklinik, Abt. f. Radiologische Diagnostik und Nuklearmedizin, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Deutschland

    Prof. Dr. Werner Golder

  44. Nephrologisches Forschungslabor, Med. Klinik IV mit Poliklinik, Friedrich-Alexander-Universität, Loschgestraße 8, 91054, Erlangen, Deutschland

    Prof. Dr. Margarete Goppelt-Strübe

  45. Institut für Pharmazie und Lebensmittelchemie, Universität Würzburg, Am Hubland, 97074, Würzburg, Deutschland

    Katharina Götte

  46. Apotheke KKH Bad Segeberg, Krankenhausstraße 2, 23795, Bad Segeberg, Deutschland

    Erkme Gottstein

  47. Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität, Institut für Pharmazie, Staudinger Weg 5, 55099, Mainz, Deutschland

    Apotheker Markus von Gruchalla

  48. Institut für Pharmazie, Universität Leipzig, Brüderstraße 34, 04103, Leipzig, Deutschland

    Dr. Michael Gütschow

  49. Pharmazeutisches Institut, Albert-Ludwigs-Universität, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Apothekerin Annette Häfner

  50. Nikolausstraße 2, 97082, Würzburg, Deutschland

    Boris Haluszczynski

  51. Geschäftsbereich Tiergesundheit, Bayer AG, Institut für Parasitologie, 51368, Leverkusen, Deutschland

    Dr. Dr. Achim Harder

  52. Weinbergstraße 1 b, 64342, Seeheim-Jugenheim, Deutschland

    Sabine Hartmann

  53. Pharmazeutisches Institut, Universität Freiburg, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Apothekerin Susanne Hartmann

  54. Pharmazeutisches Institut, Universität Kiel, Gutenbergstraße 76-78, 24118, Kiel, Deutschland

    Prof. Dr. Dieter Heber

  55. Max-von-Pettenkofer-Institut, Bundesinstiut für gesundheitlichen, Verbraucherschutz und Veterinärmedizin, Thielallee 88-92, 14195, Berlin, Deutschland

    Prof. Dr. Gerhard Heinemeyer

  56. Klosterstraße 27, 97236, Randersacker, Deutschland

    Dr. Eberhard Heller

  57. Medizinische Abteilung II, St. Joseph Krankenhaus, Bäumerplan 24, 12101, Berlin, Deutschland

    Dr. Dietrich von Herrath

  58. In der Ebene 3, 97218, Gerbrunn, Deutschland

    Dr. Ute Hoffmann-Schollmayer

  59. Abteilung für Neuroendokrinologie, MPI für experimentelle Medizin, Hermann-Rein-Str. 3, 37075, Göttingen, Deutschland

    Bernhard Hofmann

  60. Im Markthof 5, 63776, Mömbris, Deutschland

    Christian Holpert

  61. Schering AG, Forschung Diagnostika, Geschäftsbereich Pharma, Müllerstraße 178, 13342, Berlin, Deutschland

    Dr. Ute Hübner-Steiner

  62. Pharmazeutisches Institut, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Dr. Elisabeth Inkmann

  63. Rottendorf Pharma GmbH, Ostenfelder Straße 51-61, 59320, Ennigerloh, Deutschland

    Dr. Jens Jürgens

  64. Zentrum für vaskuläre Biologie und Medizin Erfurt, Friedrich-Schiller-Universität Jena, Nordhäuser Straße 78, 99089, Erfurt, Deutschland

    Priv.-Doz. Dr. Brigitte Kaiser

  65. Institut für Pharmakologie und Toxikologie, Universität Bonn, Reuterstraße 2, 53113, Bonn, Deutschland

    Prof. Dr. Dieter-Abbo Kalbhen

  66. Bundesinstitut für Arzneimittel und Medizinprodukte, Seestraße 10-11, 13353, Berlin, Deutschland

    Dr. Hans Kemmler

  67. Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität Mainz, Institut für Pharmazie, Staudinger Weg 5, 55099, Mainz, Deutschland

    Dr. Werner Kiefer

  68. Department of Pharmacology 0636, University of California, San Diego, 9500 Gilman Drive, BSB, La Jolla, California, 92093-0636, USA

    Dr. habil. Christoph Klett

  69. Allerseeweg 14, 97204, Höchberg, Deutschland

    Stephanie Klett

  70. Am Landwehrgraben 77, 26203, Wardenburg-Westerburg, Deutschland

    Dr. Martin Klingmüller

  71. Institut für Pharmakologie und Toxikologie/Bereich Erfurt, Pharmazeutische Pharmakologie und Toxikologie, Klinikum der Friedrich-Schiller-Universität Jena, Nordhäuser Straße 78, 99089, Erfurt, Deutschland

    Prof.Dr.Dr. Hans-Peter Klöcking

  72. Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Universität Erlangen-Nürnberg, Universitätsstraße 22, 91054, Erlangen, Deutschland

    Prof. Dr. Gerd Kobal

  73. Medizinische Fakultät/Institut für Hygiene und Umweltmedizin, Ernst-Moritz-Arndt-Universität, Hainstraße 26, 17493, Greifswald, Deutschland

    Prof. Dr. Axel Kramer

  74. Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität Mainz, Institut für Pharmazie, Staudinger Weg 5, 55099, Mainz, Deutschland

    Apothekerin Mareta Kreher

  75. Institut für Mikrobielle Tierseuchen, Margarete Blankstraße 8, 4103, Leipzig, Deutschland

    Prof. Dr. M. Krüger

  76. Ulmer Tor Straße 23/3, 88400, Biberach, Deutschland

    Apotheker Markus Kuhn

  77. Adalbert-Stifter-Straße 5, 92670, Windischeschenbach, Deutschland

    Marion Sylvia Lehner

  78. Wellingsbütteler Weg 13, 21762, Otterndorf, Deutschland

    Prof. Dr. Detlef Leopoldt

  79. Pharmazeutisches Institut, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Georg Liedtke

  80. Pharmazeutisches Institut, Universität Bonn, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Priv.-Doz. Dr. Detlef Manns

  81. Fachkrankenhaus Coswig, Zentrum für Pneumologie und Toraxchirurgie, Neucoswiger Straße 21, 01640, Coswig/Dresden, Deutschland

    Priv.-Doz. Dr. Wolfgang Matthiessen

  82. Pharmazeutisches Institut, Albert-Ludwigs-Universität, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Apotheker Andreas Maurer

  83. Institut für Pharmazie, Universität Regensburg, Universitätsstraße 31, 93053, Regensburg, Deutschland

    Priv.-Doz. Dr. Wolfgang Meindl

  84. Bundesinstitut für Arzneimittel und Medizinprodukte, Seestraße 10-11, 13353, Berlin, Deutschland

    Dr. Klaus Menges

  85. Abt. Pharmazeutische Chemie, Universität Hamburg Institut für Pharmazie, Bundesstraße 45, 20146, Hamburg, Deutschland

    Prof. Dr. Paul Messinger

  86. Medizinische Fakultät, Institut für Klinische Pharmakologie, Otto-von-Guericke-Universität, Leipziger Straße 44, 39120, Magdeburg, Deutschland

    Prof. Dr. Frank Peter Meyer

  87. Deutsches Institut für Ernährungsforschung, Potsdam-Rehbrücke, Arthur-Scheunert-Allee 114-116, 14558, Potsdam-Rehbrücke, Deutschland

    Prof. Wolfgang Meyerhof

  88. Abteilungsleiter Veterinärmedizin, Paul-Ehrlich-Institut, Paul-Ehrlich-Straße 51-52, 63225, Langen, Deutschland

    Prof. Manfred Moos

  89. Medizinische Fakultät der Humboldt-Universität zu Berlin, Institut für Pharmakologie und Toxikologie, Universitätsklinikum Charité, Dorotheenstraße 94, 10117, Berlin, Deutschland

    Prof. Dr. Rudolf Morgenstern

  90. Institut für Pharmazeutische Chemie, Universität Münster, Hittorfstraße 58-62, 48149, Münster, Deutschland

    Prof. Dr. Klaus Müller

  91. Pharmakologisches Institut für Naturwissenschaft, Biozentrum, Niederursel, Marie-Curie-Str. 9, 60439, Frankfurt, Deutschland

    Prof. Dr. Walter E. Müller

  92. Burggartenstr. 34, 53115, Bonn, Deutschland

    Dr. Corina Nachtsheim

  93. Peter-Bied-Straße 16, 65929, Frankfurt/M., Deutschland

    Dr. Tilo Netzer

  94. Pharmazeutisches Institut, Universität Bonn, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Priv.-Doz. Dr. Michael Neugebauer

  95. Forschungslabors des Lehrstuhls für Innere Medizin IV, Medizinische Klinik IV mit Poliklinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Kreuzburger Straße 2, 90471, Nürnberg, Deutschland

    Dr. Werner Neupert

  96. Pharmazeutisches Institut, Universität Bonn, An der Immenburg 4, 53121, Bonn, Deutschland

    Prof. Dr. Peter Nickel

  97. Fachbereich Pharmazie, Martin-Luther-Universität, Institut für Pharmazeutische Chemie, Weinbergweg 15, 06120, Halle/S., Deutschland

    Prof.Dr. habil. Peter Nuhn

  98. Institut für Pharmakologie, Freie Universität Berlin, Thielallee 69-73, 14195, Berlin, Deutschland

    Dr. Dr. Bernd Nürnberg

  99. Institut für Pharmazie, Friedrich-Schiller-Universität Jena, Philosophenweg 14, 07743, Jena, Deutschland

    Prof. Dr. H. Oelschläger

  100. Hämatologisch-onkologische Abteilung, Charité, Campus Virchow-Klinikum, Humboldt-Universität, Augustenburger Platz 1, 13353, Berlin, Deutschland

    Prof. Dr. Joachim Oertel

  101. Jenapharm GmbH & Co. KG, Otto-Schott-Straße 15, 07745, Jena, Deutschland

    Prof. Dr. Michael Oettel (Leiter Forschung und Entwicklung)

  102. Pharmakologisches Institut, Eberhard-Karls-Universität, Wilhelmstraße 56, 72074, Tübingen, Deutschland

    Prof. Dr. Hartmut Oßwald

  103. Institut für Pharmazeutische Chemie, Universität Graz, Universitätsplatz 1, 8010, Graz, Austria

    Univ.-Prof. Dr. Robert Ott

  104. Bundesinstitut für Arzneimittel und Medizinprodukte, Seestraße 10, 13353, Berlin, Deutschland

    Prof. Dr. Tilmann Ott

  105. Stadtweg 27, 24837, Schleswig, Deutschland

    Dr. Thomas Otzen

  106. Pharmazeutisches Institut Poppelsdorf, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Prof. Dr. Peter Pachaly

  107. Beim Tannenhof 24, 89079, Ulm, Deutschland

    Prof. Dr. Helmut Pelzer

  108. Oberdorfstraße 22, 52072, Aachen, Deutschland

    Prof. Dr. Karl-Uwe Petersen

  109. Pharmazeutisches Institut Poppelsdorf, Rheinische Friedrich-Wilhelms-Universität Bonn, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Rainer Pick

  110. Pharmazeutisches Institut, Universität Freiburg, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Apothekerin Martina Pickert

  111. Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität Mainz, Institut für Pharmazie, Staudinger Weg 5, 55099, Mainz, Deutschland

    Apotheker Andreas Pies

  112. Institut für Pharmazie und Lebensmittelchemie, Universität München, Sophienstraße 10, 80333, München, Deutschland

    Prof. Dr. Eberhard Reimann

  113. Nordendstraße 74, 13156, Berlin, Deutschland

    Prof. Dr. Joachim Richter

  114. Abteilung Toxikologie, Universitätsklinikum Benjamin Franklin Institut für Klinische Pharmakologie und Toxikologie, Garystraße 5, 14195, Berlin, Deutschland

    Dr. Kai Riecke

  115. Sperberstraße 16, 86343, Königsbrunn, Deutschland

    Suzanne Ritter

  116. Institut für Neuropsychopharmakologie, Freie Universität Berlin, Ulmenallee 30, 14050, Berlin, Deutschland

    Prof. Dr. Hans Rommelspacher

  117. Council of Europe, European Pharmacopoeia Commission, 224, route de Colmar, F-67000, Strasbourg, France

    Dr. Ulrich Rose

  118. Sponackerweg 3, 63808, Haibach, Deutschland

    Gernot Roth

  119. Pharmazeutisches Institut, Universität Bonn, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Prof. Dr. Gerhard Rücker

  120. Deutsches Institut für Ernährungsforschung, Potsdam-Rehbrücke, Universität Potsdam, Arthur-Scheunert-Allee 114-116, 14558, Bergholz-Rehbrücke, Deutschland

    Dr. Judith Schäfer

  121. Institut für Organische Chemie, Universität Innsbruck, Innrain 52 a, 6020, Innsbruck, Austria

    Prof. Dr. Joachim G. Schantl

  122. Randersackerer Straße 13, 97072, Würzburg, Deutschland

    Helmut Schlager

  123. Rhône-Poulenc Rorer GmbH, Nattermannallee 1, 50829, Köln, Deutschland

    Apothekerin Hildegard Schleinitz

  124. Klinik für Psychiatrie und Psychotherapie, Dr. Mackstraße 1, 86156, Augsburg, Deutschland

    Prof. Dr. Max Schmauß

  125. Institut für Pharmazeutische Chemie, Innrain 52 a, 6020, Innsbruck, Austria

    Univ.-Doz. Dr. Helmut Schmidhammer

  126. Zentrum Pharmakologie und Toxikologie, Universität Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland

    Prof. Dr. Gerhard Schmidt

  127. Unterer Dorfgraben 16, 97506, Grafenrheinfeld, Deutschland

    Timo Schmidt

  128. Karolinenhofweg 20, 12527, Berlin, Deutschland

    Prof. B. Schneeweiß

  129. Zentrales Institut des Sanitätsdienstes der Bundeswehr, Kopperpahler Allee 120, 24119, Kronshagen, Deutschland

    Oberstabsapotheker Johannes Schräder

  130. Stegemühlenweg 39, 37083, Göttingen, Deutschland

    Dr. Thomas Schulz

  131. Institut für Neuropsychopharmakologie, Ulmenallee 30, 14050, Berlin, Deutschland

    Priv.-Doz. Dr. Gert Schulze

  132. Pharmazeutisches Institut, Universität Freiburg, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Apotheker Peter Schwanz

  133. Dom Apotheke, Untere Hauptstraße 48, 85354, Freising, Deutschland

    Dr. Johannes Schweiger

  134. Institut für Rechtsmedizin, Universität Heidelberg, Voßstraße 2, 69115, Heidelberg, Deutschland

    Dr. Gisela Skopp

  135. Institut für Pharmakologie und Toxikologie, Med. Fakultät der HU zu Berlin, Dorotheenstraße 94, 10117, Berlin, Deutschland

    Dr. Gisela Skorka

  136. Institut für Pharmazie, Humboldt-Universität Berlin, Goethestraße 54, 13086, Berlin, Deutschland

    Apothekerin Kai Smolinka

  137. Schering AG, Forschung Diagnostika, Geschäftsbereich Pharma, Müllerstraße 178, 13342, Berlin, Deutschland

    Prof. Dr. Ulrich Speck

  138. Institut für Klinische Pharmakologie und Toxikologie Abteilung Toxikologie, Universitätsklinikum Benjamin Franklin, Garystraße 5, 14195, Berlin, Deutschland

    Prof. Dr. Ralf Stahlmann

  139. Bundesinstitut für Arzneimittel und Medizinprodukte, Seestraße 10-11, 13353, Berlin, Deutschland

    Dr. Herbert Stein

  140. Apotheke des Klinikums der Stadt Mannheim, Theodor-Kutzer-Ufer, 68167, Mannheim, Deutschland

    Dr. Karlheinz Stiefvater

  141. Am Park 48, 53757, St. Augustin, Deutschland

    Dr. Karl-Heinz Surborg

  142. Solvay Pharma, Werk Neustadt, Suttorfer Straße 1, 31535, Neustadt, Deutschland

    Dr. Ulf Sürig

  143. Innere Medizin: Schwerpunkt Hämatologie u. Onkologie, Uni-Klinikum Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Deutschland

    Dr. Hubert Szelényi

  144. Arzneimittelwerk Dresden GmbH, Pharmakologische Forschung, FP-2, Meißnerstraße 191, 01445, Radebeul, Deutschland

    Prof. Dr. Istvan Szelenyi

  145. Abteilung Präventiv-Medizin, Lebensmittelforschung, Dt. Institut für Ernährungsforschung, Arthur Scheunert-Allee 114-116, 14558, Bergholz-Rehbrücke, Deutschland

    Dr. Alfred Täufel

  146. Schering AG, Zentrum für Dermatologie, Max Dohrn-Straße 10, 13342, Berlin, Deutschland

    Dr. Ruth Thieroff-Ekerdt

  147. Institut für Pharmazie und Lebensmittelchemie, Schuhstraße 19, 91052, Erlangen, Deutschland

    Prof. Dr. Reinhard Troschütz

  148. Arzneimittelüberwachungsstelle SH, Holzkoppelweg 5, 24118, Kiel, Deutschland

    Dr. Michael Verborg

  149. Pharmakologie für Naturwissenschaftler, Westfälische Wilhelms-Universität, Institut für Pharmazeutische Chemie, Hittorfstraße 58-62, 48149, Münster, Deutschland

    Prof. Dr. Eugen J. Verspohl

  150. Finkenweg 11, 95119, Naila, Deutschland

    Dr. Sabine Vogel

  151. Pharmazeutisches Institut, Albert-Ludwigs-Universität, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Apotheker Franz-Josef Volk

  152. Institut für Pharmazie, Humboldt-Universität zu Berlin, Goethestraße 54, 13086, Berlin, Deutschland

    Apotheker Thomas Vorwerk

  153. Fregestraße 80, 12159, Berlin, Deutschland

    Dr. Jürgen Wallmann

  154. WEH: Institut für Pharmazie, Königin-Luise-Straße 2 + 4, 14195, Berlin, Deutschland

    Prof. Dr. Martin Wenzel

  155. Am Rittweg 10, 77654, Offenburg, Deutschland

    Dr. Marion Weyandt-Spangenberg

  156. Am Ludwigsland 4, 96364, Marktrodach, Deutschland

    Sandra Wich

  157. Institut für Pharmazeutische Chemie, Karl-Franzens-Universität, Schubertsstraße 1, 8010, Graz, Austria

    Prof. Dr. Reinhold Wintersteiger

  158. Rappoltsweiler Winkel 5, 68229, Mannheim, Deutschland

    Dr. Frauke Woltmann

  159. Pharmazeutisches Institut, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Dipl.-Chem. Beate Wüst

  160. Institut für Immunologie, Im Neuenheimer Feld 305, 69120, Heidelberg, Deutschland

    Frau Priv.-Doz. Dr. G. Zilow

Authors
  1. Professor Dr. Franz von Bruchhausen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Professor Dr. Siegfried Ebel
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Professor Dr. Eberhard Hackenthal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Professor Dr. Ulrike Holzgrabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Priv.-Doz. Dr. Margitta Albinus
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Apothekerin Gudrun Amschler
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Prof. Dr. Erwin von Angerer
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Dr. C. Arras-Reiter
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Apothekerin Andrea Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Pia Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Priv.-Doz. Dr. Winfried Beil
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Prof. Dr. Thorsten Beyrich
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Katja Binder
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Dr. Roswitha Böhme
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Prof. Dr. Hans-Hubertus Borchert
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Franz Bossle
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Prof. Dr. Franz Bracher
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Prof. Dr. Helmut Bräunlich
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Dr. Ellen Bretschneider
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Dr. Regina Brigelius-Flohé
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Kerstin Brinkmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Prof. Dr. Axel Büge
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Prof. Dr. Wolfram Christ
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Monika Cimbollek
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Dr. Rolf Daniels
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Prof. Dr. Gerd Dannhardt
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. Prof. Dr. Hans-Jürgen Duchstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. Prof. Dr. Kurt Eger
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. Dr. Petra Eichhorn
    View author publications

    You can also search for this author in PubMed Google Scholar

  30. Dipl.-Chem. Michael Engler
    View author publications

    You can also search for this author in PubMed Google Scholar

  31. Dr. Thomas Erker
    View author publications

    You can also search for this author in PubMed Google Scholar

  32. Prof. Dr. Peter Felfe
    View author publications

    You can also search for this author in PubMed Google Scholar

  33. Dr. Alfred Fenyves
    View author publications

    You can also search for this author in PubMed Google Scholar

  34. Dr. Reinhard Fescharek
    View author publications

    You can also search for this author in PubMed Google Scholar

  35. Carmen Frackenpohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  36. Prof. Dr. August Wilhelm Frahm
    View author publications

    You can also search for this author in PubMed Google Scholar

  37. Dr. Margarete Frahm
    View author publications

    You can also search for this author in PubMed Google Scholar

  38. Dr. Volker Franke
    View author publications

    You can also search for this author in PubMed Google Scholar

  39. Ulrich Franken
    View author publications

    You can also search for this author in PubMed Google Scholar

  40. Prof. Dr. Detlef Geffken
    View author publications

    You can also search for this author in PubMed Google Scholar

  41. Apotheker Uli Geis
    View author publications

    You can also search for this author in PubMed Google Scholar

  42. Prof. Dr. Erika Glusa
    View author publications

    You can also search for this author in PubMed Google Scholar

  43. Prof. Dr. Berthold Göber
    View author publications

    You can also search for this author in PubMed Google Scholar

  44. Peter Ndive Gobina
    View author publications

    You can also search for this author in PubMed Google Scholar

  45. Prof. Dr. Werner Golder
    View author publications

    You can also search for this author in PubMed Google Scholar

  46. Prof. Dr. Margarete Goppelt-Strübe
    View author publications

    You can also search for this author in PubMed Google Scholar

  47. Katharina Götte
    View author publications

    You can also search for this author in PubMed Google Scholar

  48. Erkme Gottstein
    View author publications

    You can also search for this author in PubMed Google Scholar

  49. Apotheker Michael Grosam
    View author publications

    You can also search for this author in PubMed Google Scholar

  50. Apotheker Markus von Gruchalla
    View author publications

    You can also search for this author in PubMed Google Scholar

  51. Dr. Michael Gütschow
    View author publications

    You can also search for this author in PubMed Google Scholar

  52. Apothekerin Annette Häfner
    View author publications

    You can also search for this author in PubMed Google Scholar

  53. Boris Haluszczynski
    View author publications

    You can also search for this author in PubMed Google Scholar

  54. Dr. Dr. Achim Harder
    View author publications

    You can also search for this author in PubMed Google Scholar

  55. Sabine Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  56. Apothekerin Susanne Hartmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  57. Prof. Dr. Dieter Heber
    View author publications

    You can also search for this author in PubMed Google Scholar

  58. Prof. Dr. Gerhard Heinemeyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  59. Dr. Eberhard Heller
    View author publications

    You can also search for this author in PubMed Google Scholar

  60. Dr. Dietrich von Herrath
    View author publications

    You can also search for this author in PubMed Google Scholar

  61. Dr. J. Hilfenhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  62. Dr. Ute Hoffmann-Schollmayer
    View author publications

    You can also search for this author in PubMed Google Scholar

  63. Bernhard Hofmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  64. Christian Holpert
    View author publications

    You can also search for this author in PubMed Google Scholar

  65. Dr. Ute Hübner-Steiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  66. Dr. Elisabeth Inkmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  67. Dr. Jens Jürgens
    View author publications

    You can also search for this author in PubMed Google Scholar

  68. Priv.-Doz. Dr. Brigitte Kaiser
    View author publications

    You can also search for this author in PubMed Google Scholar

  69. Prof. Dr. Dieter-Abbo Kalbhen
    View author publications

    You can also search for this author in PubMed Google Scholar

  70. Dr. Hans Kemmler
    View author publications

    You can also search for this author in PubMed Google Scholar

  71. Dr. Werner Kiefer
    View author publications

    You can also search for this author in PubMed Google Scholar

  72. Dr. habil. Christoph Klett
    View author publications

    You can also search for this author in PubMed Google Scholar

  73. Stephanie Klett
    View author publications

    You can also search for this author in PubMed Google Scholar

  74. Dr. Martin Klingmüller
    View author publications

    You can also search for this author in PubMed Google Scholar

  75. Prof.Dr.Dr. Hans-Peter Klöcking
    View author publications

    You can also search for this author in PubMed Google Scholar

  76. Prof. Dr. Gerd Kobal
    View author publications

    You can also search for this author in PubMed Google Scholar

  77. Prof. Dr. Axel Kramer
    View author publications

    You can also search for this author in PubMed Google Scholar

  78. Apothekerin Mareta Kreher
    View author publications

    You can also search for this author in PubMed Google Scholar

  79. Prof. Dr. M. Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

  80. Apotheker Markus Kuhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  81. Marion Sylvia Lehner
    View author publications

    You can also search for this author in PubMed Google Scholar

  82. Prof. Dr. Detlef Leopoldt
    View author publications

    You can also search for this author in PubMed Google Scholar

  83. Georg Liedtke
    View author publications

    You can also search for this author in PubMed Google Scholar

  84. Priv.-Doz. Dr. Detlef Manns
    View author publications

    You can also search for this author in PubMed Google Scholar

  85. Priv.-Doz. Dr. Wolfgang Matthiessen
    View author publications

    You can also search for this author in PubMed Google Scholar

  86. Apotheker Andreas Maurer
    View author publications

    You can also search for this author in PubMed Google Scholar

  87. Priv.-Doz. Dr. Wolfgang Meindl
    View author publications

    You can also search for this author in PubMed Google Scholar

  88. Dr. Klaus Menges
    View author publications

    You can also search for this author in PubMed Google Scholar

  89. Prof. Dr. Paul Messinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  90. Prof. Dr. Frank Peter Meyer
    View author publications

    You can also search for this author in PubMed Google Scholar

  91. Prof. Wolfgang Meyerhof
    View author publications

    You can also search for this author in PubMed Google Scholar

  92. Prof. Manfred Moos
    View author publications

    You can also search for this author in PubMed Google Scholar

  93. Prof. Dr. Rudolf Morgenstern
    View author publications

    You can also search for this author in PubMed Google Scholar

  94. Prof. Dr. Klaus Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  95. Prof. Dr. Walter E. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  96. Dr. Corina Nachtsheim
    View author publications

    You can also search for this author in PubMed Google Scholar

  97. Dr. Tilo Netzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  98. Priv.-Doz. Dr. Michael Neugebauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  99. Dr. Werner Neupert
    View author publications

    You can also search for this author in PubMed Google Scholar

  100. Prof. Dr. Peter Nickel
    View author publications

    You can also search for this author in PubMed Google Scholar

  101. Prof.Dr. habil. Peter Nuhn
    View author publications

    You can also search for this author in PubMed Google Scholar

  102. Dr. Dr. Bernd Nürnberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  103. Prof. Dr. H. Oelschläger
    View author publications

    You can also search for this author in PubMed Google Scholar

  104. Prof. Dr. Joachim Oertel
    View author publications

    You can also search for this author in PubMed Google Scholar

  105. Prof. Dr. Michael Oettel
    View author publications

    You can also search for this author in PubMed Google Scholar

  106. Prof. Dr. Hartmut Oßwald
    View author publications

    You can also search for this author in PubMed Google Scholar

  107. Univ.-Prof. Dr. Robert Ott
    View author publications

    You can also search for this author in PubMed Google Scholar

  108. Prof. Dr. Tilmann Ott
    View author publications

    You can also search for this author in PubMed Google Scholar

  109. Dr. Thomas Otzen
    View author publications

    You can also search for this author in PubMed Google Scholar

  110. Prof. Dr. Peter Pachaly
    View author publications

    You can also search for this author in PubMed Google Scholar

  111. Prof. Dr. Helmut Pelzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  112. Prof. Dr. Karl-Uwe Petersen
    View author publications

    You can also search for this author in PubMed Google Scholar

  113. Rainer Pick
    View author publications

    You can also search for this author in PubMed Google Scholar

  114. Apothekerin Martina Pickert
    View author publications

    You can also search for this author in PubMed Google Scholar

  115. Apotheker Andreas Pies
    View author publications

    You can also search for this author in PubMed Google Scholar

  116. Prof. Dr. Eberhard Reimann
    View author publications

    You can also search for this author in PubMed Google Scholar

  117. Prof. Dr. Joachim Richter
    View author publications

    You can also search for this author in PubMed Google Scholar

  118. Dr. Kai Riecke
    View author publications

    You can also search for this author in PubMed Google Scholar

  119. Suzanne Ritter
    View author publications

    You can also search for this author in PubMed Google Scholar

  120. Prof. Dr. Hans Rommelspacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  121. Dr. Ulrich Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  122. Gernot Roth
    View author publications

    You can also search for this author in PubMed Google Scholar

  123. Prof. Dr. Gerhard Rücker
    View author publications

    You can also search for this author in PubMed Google Scholar

  124. Dr. Judith Schäfer
    View author publications

    You can also search for this author in PubMed Google Scholar

  125. Prof. Dr. Joachim G. Schantl
    View author publications

    You can also search for this author in PubMed Google Scholar

  126. Helmut Schlager
    View author publications

    You can also search for this author in PubMed Google Scholar

  127. Apothekerin Hildegard Schleinitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  128. Prof. Dr. Max Schmauß
    View author publications

    You can also search for this author in PubMed Google Scholar

  129. Univ.-Doz. Dr. Helmut Schmidhammer
    View author publications

    You can also search for this author in PubMed Google Scholar

  130. Prof. Dr. Gerhard Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  131. Timo Schmidt
    View author publications

    You can also search for this author in PubMed Google Scholar

  132. Prof. B. Schneeweiß
    View author publications

    You can also search for this author in PubMed Google Scholar

  133. Oberstabsapotheker Johannes Schräder
    View author publications

    You can also search for this author in PubMed Google Scholar

  134. Dr. Thomas Schulz
    View author publications

    You can also search for this author in PubMed Google Scholar

  135. Priv.-Doz. Dr. Gert Schulze
    View author publications

    You can also search for this author in PubMed Google Scholar

  136. Apotheker Peter Schwanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  137. Dr. Johannes Schweiger
    View author publications

    You can also search for this author in PubMed Google Scholar

  138. Dr. Gisela Skopp
    View author publications

    You can also search for this author in PubMed Google Scholar

  139. Dr. Gisela Skorka
    View author publications

    You can also search for this author in PubMed Google Scholar

  140. Apothekerin Kai Smolinka
    View author publications

    You can also search for this author in PubMed Google Scholar

  141. Prof. Dr. Ulrich Speck
    View author publications

    You can also search for this author in PubMed Google Scholar

  142. Prof. Dr. Ralf Stahlmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  143. Dr. Herbert Stein
    View author publications

    You can also search for this author in PubMed Google Scholar

  144. Dr. Karlheinz Stiefvater
    View author publications

    You can also search for this author in PubMed Google Scholar

  145. Dr. Karl-Heinz Surborg
    View author publications

    You can also search for this author in PubMed Google Scholar

  146. Dr. Ulf Sürig
    View author publications

    You can also search for this author in PubMed Google Scholar

  147. Dr. Hubert Szelényi
    View author publications

    You can also search for this author in PubMed Google Scholar

  148. Prof. Dr. Istvan Szelenyi
    View author publications

    You can also search for this author in PubMed Google Scholar

  149. Dr. Alfred Täufel
    View author publications

    You can also search for this author in PubMed Google Scholar

  150. Dr. Ruth Thieroff-Ekerdt
    View author publications

    You can also search for this author in PubMed Google Scholar

  151. Prof. Dr. Reinhard Troschütz
    View author publications

    You can also search for this author in PubMed Google Scholar

  152. Dr. Michael Verborg
    View author publications

    You can also search for this author in PubMed Google Scholar

  153. Prof. Dr. Eugen J. Verspohl
    View author publications

    You can also search for this author in PubMed Google Scholar

  154. Dr. Sabine Vogel
    View author publications

    You can also search for this author in PubMed Google Scholar

  155. Apotheker Franz-Josef Volk
    View author publications

    You can also search for this author in PubMed Google Scholar

  156. Apotheker Thomas Vorwerk
    View author publications

    You can also search for this author in PubMed Google Scholar

  157. Dr. Jürgen Wallmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  158. Prof. Dr. Martin Wenzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  159. Dr. Marion Weyandt-Spangenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  160. Sandra Wich
    View author publications

    You can also search for this author in PubMed Google Scholar

  161. Prof. Dr. Reinhold Wintersteiger
    View author publications

    You can also search for this author in PubMed Google Scholar

  162. Dr. Frauke Woltmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  163. Dipl.-Chem. Beate Wüst
    View author publications

    You can also search for this author in PubMed Google Scholar

  164. Frau Priv.-Doz. Dr. G. Zilow
    View author publications

    You can also search for this author in PubMed Google Scholar

  165. A. Kluge
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pharmakologie, Freie Universität Berlin, Thielallee 69-73, 14195, Berlin, Deutschland

    Franz von Bruchhausen

  2. Institut für Pharmazie und Lebensmittelchemie, Universität Würzburg, Am Hubland, 97074, Würzburg, Deutschland

    Siegfried Ebel  & Ulrike Holzgrabe  & 

  3. Birkenweg 20, 69221, Dossenheim, Deutschland

    Eberhard Hackenthal

  4. Pharmakologisches Institut, Eberhard-Karls-Universität, Wilhelmstraße 56, 72074, Tübingen, Deutschland

    Margitta Albinus

  5. Pharmazeutisches Institut, Universität Freiburg, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Gudrun Amschler

  6. Institut für Pharmazie, Universität Regensburg, Universitätsstraße 31, 93040, Regensburg, Deutschland

    Erwin von Angerer

  7. Chiron-Behring, Postfach 1630, 35006, Marburg, Deutschland

    C. Arras-Reiter

  8. Institut für Pharmazie Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität Mainz, Staudinger Weg 5, 55099, Mainz, Deutschland

    Andrea Bauer

  9. An der Steige 18, 73642, Welzheim, Deutschland

    Pia Bauer

  10. Allgemeine Pharmakologie — Abteilung I, Medizinische Hochschule Hannover, 30601, Hannover, Deutschland

    Winfried Beil

  11. Fachbereich Pharmazie, Ernst-Moritz-Arndt-Universität, Friedrich-Ludwig-Jahn-Straße 17, 17489, Greifswald, Deutschland

    Thorsten Beyrich

  12. Kilianstraße 4, 97762, Hammelburg, Deutschland

    Katja Binder

  13. Paracelsusstraße 40, 53757, Sankt Augustin, Deutschland

    Roswitha Böhme

  14. Institut für Pharmazie, Humboldt-Universität zu Berlin, Goethestraße 54, 13086, Berlin, Deutschland

    Hans-Hubertus Borchert

  15. Roßmarkt 14, 97421, Schweinfurt, Deutschland

    Franz Bossle

  16. Institut für Pharmazie, Sophienstraße 10, 80333, München, Deutschland

    Franz Bracher

  17. Dorfstraße 31 a, 99510, Hermstedt, Deutschland

    Helmut Bräunlich

  18. Zentrum für Vaskuläre Biologie und Medizin, Friedrich-Schiller-Universität Jena, Institut für Experimentelle Angiologie und Hämostaseologie, Nordhäuser Straße 78, 99089, Erfurt, Deutschland

    Ellen Bretschneider

  19. AG Vitamine/Atherosklerose, Deutsches Institut für Ernährungsforschung, Potsdam-Rehbrücke Arthur Scheunert-Allee 114-116, 14558, Bergholz-Rehbrücke, Deutschland

    Regina Brigelius-Flohé

  20. In der Ebene 11, 97218, Gerbrunn, Deutschland

    Kerstin Brinkmann

  21. Institut für Pharmazeutische Chemie, Martin-Luther-Universität, Weinbergweg 15, 06120, Halle, Deutschland

    Axel Büge

  22. Bundesinstitut für Arzneimittel und Medizinprodukte, Seestraße 10, 13353, Berlin, Deutschland

    Wolfram Christ

  23. Lange Rötterstraße 26, 68167, Mannheim, Deutschland

    Monika Cimbollek

  24. Institut für Pharmazie, Universität Regensburg, Universitätsstraße 31, 93053, Regensburg, Deutschland

    Rolf Daniels

  25. Institut für Pharmazie Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität, Staudinger Weg 5, 55099, Mainz, Deutschland

    Gerd Dannhardt

  26. Institut für Pharmazie Abteilung Pharmazeutische Chemie, Universität Hamburg, Bundesstraße 45, 20146, Hamburg, Deutschland

    Hans-Jürgen Duchstein

  27. Institut für Pharmazie, Universität Leipzig, Brüderstraße 34, 04103, Leipzig, Deutschland

    Kurt Eger

  28. Heidelberger Straße 29, 64342, Seeheim, Deutschland

    Petra Eichhorn

  29. Pharmazeutisches Institut, Universität Bonn, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Michael Engler

  30. Pharmaziezentrum der Universität Wien, Althanstraße 14, 1090, Wien, Deutschland

    Thomas Erker

  31. Am Hang 5, 17498, Riemersort, Deutschland

    Peter Felfe

  32. Frankenstraße 17, 63128, Dietzenbach, Deutschland

    Alfred Fenyves

  33. Sankyo Pharma GmbH, Zielstattstraße 9, 81379, München, Deutschland

    Reinhard Fescharek (Leiter der Arzneimittelsicherheit) (Leiter der Arzneimittelsicherheit)

  34. Pharmazeutisches Institut, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Carmen Frackenpohl

  35. Lehrstuhl für Pharmazeutische Chemie, Universität Freiburg, Pharmazeutisches Institut, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    August Wilhelm Frahm

  36. Behringwerke AG, 35001, Marburg, Deutschland

    Volker Franke

  37. Balneopharm Cordes & Co., 30826, Garbsen, Deutschland

    Ulrich Franken

  38. Abteilung für Pharmazeutische Chemie, Institut für Pharmazie, Bundesstraße 45, 20146, Hamburg, Deutschland

    Detlef Geffken

  39. Winterleitenweg 61 a, 97082, Würzburg, Deutschland

    Uli Geis

  40. Institut für Experimentelle Angiologie und Hämostaseologie Zentrum für Vaskuläre Biologie und Medizin, Klinikum der Friedrich-Schiller-Universität Jena, Nordhäuser Straße 78, 99089, Erfurt, Deutschland

    Erika Glusa

  41. Institut für Pharmazie, Humboldt-Universität zu Berlin, Goethestraße 54, 13086, Berlin, Deutschland

    Berthold Göber

  42. Pharmazeutisches Institut, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Peter Ndive Gobina

  43. Fachbereich Humanmedizin, Radiologische Klinik u. Poliklinik, Abt. f. Radiologische Diagnostik und Nuklearmedizin, Universitätsklinikum Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Deutschland

    Werner Golder

  44. Nephrologisches Forschungslabor, Med. Klinik IV mit Poliklinik, Friedrich-Alexander-Universität, Loschgestraße 8, 91054, Erlangen, Deutschland

    Margarete Goppelt-Strübe

  45. Institut für Pharmazie und Lebensmittelchemie, Universität Würzburg, Am Hubland, 97074, Würzburg, Deutschland

    Katharina Götte

  46. Apotheke KKH Bad Segeberg, Krankenhausstraße 2, 23795, Bad Segeberg, Deutschland

    Erkme Gottstein

  47. Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität, Institut für Pharmazie, Staudinger Weg 5, 55099, Mainz, Deutschland

    Markus von Gruchalla

  48. Institut für Pharmazie, Universität Leipzig, Brüderstraße 34, 04103, Leipzig, Deutschland

    Michael Gütschow

  49. Pharmazeutisches Institut, Albert-Ludwigs-Universität, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Annette Häfner

  50. Nikolausstraße 2, 97082, Würzburg, Deutschland

    Boris Haluszczynski

  51. Geschäftsbereich Tiergesundheit, Bayer AG, Institut für Parasitologie, 51368, Leverkusen, Deutschland

    Achim Harder

  52. Weinbergstraße 1 b, 64342, Seeheim-Jugenheim, Deutschland

    Sabine Hartmann

  53. Pharmazeutisches Institut, Universität Freiburg, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Susanne Hartmann

  54. Pharmazeutisches Institut, Universität Kiel, Gutenbergstraße 76-78, 24118, Kiel, Deutschland

    Dieter Heber

  55. Max-von-Pettenkofer-Institut, Bundesinstiut für gesundheitlichen, Verbraucherschutz und Veterinärmedizin, Thielallee 88-92, 14195, Berlin, Deutschland

    Gerhard Heinemeyer

  56. Klosterstraße 27, 97236, Randersacker, Deutschland

    Eberhard Heller

  57. Medizinische Abteilung II, St. Joseph Krankenhaus, Bäumerplan 24, 12101, Berlin, Deutschland

    Dietrich von Herrath

  58. In der Ebene 3, 97218, Gerbrunn, Deutschland

    Ute Hoffmann-Schollmayer

  59. Abteilung für Neuroendokrinologie, MPI für experimentelle Medizin, Hermann-Rein-Str. 3, 37075, Göttingen, Deutschland

    Bernhard Hofmann

  60. Im Markthof 5, 63776, Mömbris, Deutschland

    Christian Holpert

  61. Schering AG, Forschung Diagnostika, Geschäftsbereich Pharma, Müllerstraße 178, 13342, Berlin, Deutschland

    Ute Hübner-Steiner

  62. Pharmazeutisches Institut, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Elisabeth Inkmann

  63. Rottendorf Pharma GmbH, Ostenfelder Straße 51-61, 59320, Ennigerloh, Deutschland

    Jens Jürgens

  64. Zentrum für vaskuläre Biologie und Medizin Erfurt, Friedrich-Schiller-Universität Jena, Nordhäuser Straße 78, 99089, Erfurt, Deutschland

    Brigitte Kaiser

  65. Institut für Pharmakologie und Toxikologie, Universität Bonn, Reuterstraße 2, 53113, Bonn, Deutschland

    Dieter-Abbo Kalbhen

  66. Bundesinstitut für Arzneimittel und Medizinprodukte, Seestraße 10-11, 13353, Berlin, Deutschland

    Hans Kemmler

  67. Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität Mainz, Institut für Pharmazie, Staudinger Weg 5, 55099, Mainz, Deutschland

    Werner Kiefer

  68. Department of Pharmacology 0636, University of California, San Diego, 9500 Gilman Drive, BSB, La Jolla, California, 92093-0636, USA

    Christoph Klett

  69. Allerseeweg 14, 97204, Höchberg, Deutschland

    Stephanie Klett

  70. Am Landwehrgraben 77, 26203, Wardenburg-Westerburg, Deutschland

    Martin Klingmüller

  71. Institut für Pharmakologie und Toxikologie/Bereich Erfurt, Pharmazeutische Pharmakologie und Toxikologie, Klinikum der Friedrich-Schiller-Universität Jena, Nordhäuser Straße 78, 99089, Erfurt, Deutschland

    Hans-Peter Klöcking

  72. Institut für Experimentelle und Klinische Pharmakologie und Toxikologie, Universität Erlangen-Nürnberg, Universitätsstraße 22, 91054, Erlangen, Deutschland

    Gerd Kobal

  73. Medizinische Fakultät/Institut für Hygiene und Umweltmedizin, Ernst-Moritz-Arndt-Universität, Hainstraße 26, 17493, Greifswald, Deutschland

    Axel Kramer

  74. Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität Mainz, Institut für Pharmazie, Staudinger Weg 5, 55099, Mainz, Deutschland

    Mareta Kreher

  75. Institut für Mikrobielle Tierseuchen, Margarete Blankstraße 8, 4103, Leipzig, Deutschland

    M. Krüger

  76. Ulmer Tor Straße 23/3, 88400, Biberach, Deutschland

    Markus Kuhn

  77. Adalbert-Stifter-Straße 5, 92670, Windischeschenbach, Deutschland

    Marion Sylvia Lehner

  78. Wellingsbütteler Weg 13, 21762, Otterndorf, Deutschland

    Detlef Leopoldt

  79. Pharmazeutisches Institut, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Georg Liedtke

  80. Pharmazeutisches Institut, Universität Bonn, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Detlef Manns

  81. Fachkrankenhaus Coswig, Zentrum für Pneumologie und Toraxchirurgie, Neucoswiger Straße 21, 01640, Coswig/Dresden, Deutschland

    Wolfgang Matthiessen

  82. Pharmazeutisches Institut, Albert-Ludwigs-Universität, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Andreas Maurer

  83. Institut für Pharmazie, Universität Regensburg, Universitätsstraße 31, 93053, Regensburg, Deutschland

    Wolfgang Meindl

  84. Bundesinstitut für Arzneimittel und Medizinprodukte, Seestraße 10-11, 13353, Berlin, Deutschland

    Klaus Menges

  85. Abt. Pharmazeutische Chemie, Universität Hamburg Institut für Pharmazie, Bundesstraße 45, 20146, Hamburg, Deutschland

    Paul Messinger

  86. Medizinische Fakultät, Institut für Klinische Pharmakologie, Otto-von-Guericke-Universität, Leipziger Straße 44, 39120, Magdeburg, Deutschland

    Frank Peter Meyer

  87. Deutsches Institut für Ernährungsforschung, Potsdam-Rehbrücke, Arthur-Scheunert-Allee 114-116, 14558, Potsdam-Rehbrücke, Deutschland

    Wolfgang Meyerhof

  88. Abteilungsleiter Veterinärmedizin, Paul-Ehrlich-Institut, Paul-Ehrlich-Straße 51-52, 63225, Langen, Deutschland

    Manfred Moos

  89. Medizinische Fakultät der Humboldt-Universität zu Berlin, Institut für Pharmakologie und Toxikologie, Universitätsklinikum Charité, Dorotheenstraße 94, 10117, Berlin, Deutschland

    Rudolf Morgenstern

  90. Institut für Pharmazeutische Chemie, Universität Münster, Hittorfstraße 58-62, 48149, Münster, Deutschland

    Klaus Müller

  91. Pharmakologisches Institut für Naturwissenschaft, Biozentrum, Niederursel, Marie-Curie-Str. 9, 60439, Frankfurt, Deutschland

    Walter E. Müller

  92. Burggartenstr. 34, 53115, Bonn, Deutschland

    Corina Nachtsheim

  93. Peter-Bied-Straße 16, 65929, Frankfurt/M., Deutschland

    Tilo Netzer

  94. Pharmazeutisches Institut, Universität Bonn, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Michael Neugebauer

  95. Forschungslabors des Lehrstuhls für Innere Medizin IV, Medizinische Klinik IV mit Poliklinik, Friedrich-Alexander-Universität Erlangen-Nürnberg, Kreuzburger Straße 2, 90471, Nürnberg, Deutschland

    Werner Neupert

  96. Pharmazeutisches Institut, Universität Bonn, An der Immenburg 4, 53121, Bonn, Deutschland

    Peter Nickel

  97. Fachbereich Pharmazie, Martin-Luther-Universität, Institut für Pharmazeutische Chemie, Weinbergweg 15, 06120, Halle/S., Deutschland

    Peter Nuhn

  98. Institut für Pharmakologie, Freie Universität Berlin, Thielallee 69-73, 14195, Berlin, Deutschland

    Bernd Nürnberg

  99. Institut für Pharmazie, Friedrich-Schiller-Universität Jena, Philosophenweg 14, 07743, Jena, Deutschland

    H. Oelschläger

  100. Hämatologisch-onkologische Abteilung, Charité, Campus Virchow-Klinikum, Humboldt-Universität, Augustenburger Platz 1, 13353, Berlin, Deutschland

    Joachim Oertel

  101. Jenapharm GmbH & Co. KG, Otto-Schott-Straße 15, 07745, Jena, Deutschland

    Michael Oettel (Leiter Forschung und Entwicklung) (Leiter Forschung und Entwicklung)

  102. Pharmakologisches Institut, Eberhard-Karls-Universität, Wilhelmstraße 56, 72074, Tübingen, Deutschland

    Hartmut Oßwald

  103. Institut für Pharmazeutische Chemie, Universität Graz, Universitätsplatz 1, 8010, Graz, Austria

    Robert Ott

  104. Bundesinstitut für Arzneimittel und Medizinprodukte, Seestraße 10, 13353, Berlin, Deutschland

    Tilmann Ott

  105. Stadtweg 27, 24837, Schleswig, Deutschland

    Thomas Otzen

  106. Pharmazeutisches Institut Poppelsdorf, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Peter Pachaly

  107. Beim Tannenhof 24, 89079, Ulm, Deutschland

    Helmut Pelzer

  108. Oberdorfstraße 22, 52072, Aachen, Deutschland

    Karl-Uwe Petersen

  109. Pharmazeutisches Institut Poppelsdorf, Rheinische Friedrich-Wilhelms-Universität Bonn, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Rainer Pick

  110. Pharmazeutisches Institut, Universität Freiburg, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Martina Pickert

  111. Fachbereich Chemie und Pharmazie, Johannes Gutenberg-Universität Mainz, Institut für Pharmazie, Staudinger Weg 5, 55099, Mainz, Deutschland

    Andreas Pies

  112. Institut für Pharmazie und Lebensmittelchemie, Universität München, Sophienstraße 10, 80333, München, Deutschland

    Eberhard Reimann

  113. Nordendstraße 74, 13156, Berlin, Deutschland

    Joachim Richter

  114. Abteilung Toxikologie, Universitätsklinikum Benjamin Franklin Institut für Klinische Pharmakologie und Toxikologie, Garystraße 5, 14195, Berlin, Deutschland

    Kai Riecke

  115. Sperberstraße 16, 86343, Königsbrunn, Deutschland

    Suzanne Ritter

  116. Institut für Neuropsychopharmakologie, Freie Universität Berlin, Ulmenallee 30, 14050, Berlin, Deutschland

    Hans Rommelspacher

  117. Council of Europe, European Pharmacopoeia Commission, 224, route de Colmar, F-67000, Strasbourg, France

    Ulrich Rose

  118. Sponackerweg 3, 63808, Haibach, Deutschland

    Gernot Roth

  119. Pharmazeutisches Institut, Universität Bonn, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Gerhard Rücker

  120. Deutsches Institut für Ernährungsforschung, Potsdam-Rehbrücke, Universität Potsdam, Arthur-Scheunert-Allee 114-116, 14558, Bergholz-Rehbrücke, Deutschland

    Judith Schäfer

  121. Institut für Organische Chemie, Universität Innsbruck, Innrain 52 a, 6020, Innsbruck, Austria

    Joachim G. Schantl

  122. Randersackerer Straße 13, 97072, Würzburg, Deutschland

    Helmut Schlager

  123. Rhône-Poulenc Rorer GmbH, Nattermannallee 1, 50829, Köln, Deutschland

    Hildegard Schleinitz

  124. Klinik für Psychiatrie und Psychotherapie, Dr. Mackstraße 1, 86156, Augsburg, Deutschland

    Max Schmauß

  125. Institut für Pharmazeutische Chemie, Innrain 52 a, 6020, Innsbruck, Austria

    Helmut Schmidhammer

  126. Zentrum Pharmakologie und Toxikologie, Universität Göttingen, Robert-Koch-Straße 40, 37075, Göttingen, Deutschland

    Gerhard Schmidt

  127. Unterer Dorfgraben 16, 97506, Grafenrheinfeld, Deutschland

    Timo Schmidt

  128. Karolinenhofweg 20, 12527, Berlin, Deutschland

    B. Schneeweiß

  129. Zentrales Institut des Sanitätsdienstes der Bundeswehr, Kopperpahler Allee 120, 24119, Kronshagen, Deutschland

    Johannes Schräder

  130. Stegemühlenweg 39, 37083, Göttingen, Deutschland

    Thomas Schulz

  131. Institut für Neuropsychopharmakologie, Ulmenallee 30, 14050, Berlin, Deutschland

    Gert Schulze

  132. Pharmazeutisches Institut, Universität Freiburg, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Peter Schwanz

  133. Dom Apotheke, Untere Hauptstraße 48, 85354, Freising, Deutschland

    Johannes Schweiger

  134. Institut für Rechtsmedizin, Universität Heidelberg, Voßstraße 2, 69115, Heidelberg, Deutschland

    Gisela Skopp

  135. Institut für Pharmakologie und Toxikologie, Med. Fakultät der HU zu Berlin, Dorotheenstraße 94, 10117, Berlin, Deutschland

    Gisela Skorka

  136. Institut für Pharmazie, Humboldt-Universität Berlin, Goethestraße 54, 13086, Berlin, Deutschland

    Kai Smolinka

  137. Schering AG, Forschung Diagnostika, Geschäftsbereich Pharma, Müllerstraße 178, 13342, Berlin, Deutschland

    Ulrich Speck

  138. Institut für Klinische Pharmakologie und Toxikologie Abteilung Toxikologie, Universitätsklinikum Benjamin Franklin, Garystraße 5, 14195, Berlin, Deutschland

    Ralf Stahlmann

  139. Bundesinstitut für Arzneimittel und Medizinprodukte, Seestraße 10-11, 13353, Berlin, Deutschland

    Herbert Stein

  140. Apotheke des Klinikums der Stadt Mannheim, Theodor-Kutzer-Ufer, 68167, Mannheim, Deutschland

    Karlheinz Stiefvater

  141. Am Park 48, 53757, St. Augustin, Deutschland

    Karl-Heinz Surborg

  142. Solvay Pharma, Werk Neustadt, Suttorfer Straße 1, 31535, Neustadt, Deutschland

    Ulf Sürig

  143. Innere Medizin: Schwerpunkt Hämatologie u. Onkologie, Uni-Klinikum Benjamin Franklin, Hindenburgdamm 30, 12200, Berlin, Deutschland

    Hubert Szelényi

  144. Arzneimittelwerk Dresden GmbH, Pharmakologische Forschung, FP-2, Meißnerstraße 191, 01445, Radebeul, Deutschland

    Istvan Szelenyi

  145. Abteilung Präventiv-Medizin, Lebensmittelforschung, Dt. Institut für Ernährungsforschung, Arthur Scheunert-Allee 114-116, 14558, Bergholz-Rehbrücke, Deutschland

    Alfred Täufel

  146. Schering AG, Zentrum für Dermatologie, Max Dohrn-Straße 10, 13342, Berlin, Deutschland

    Ruth Thieroff-Ekerdt

  147. Institut für Pharmazie und Lebensmittelchemie, Schuhstraße 19, 91052, Erlangen, Deutschland

    Reinhard Troschütz

  148. Arzneimittelüberwachungsstelle SH, Holzkoppelweg 5, 24118, Kiel, Deutschland

    Michael Verborg

  149. Pharmakologie für Naturwissenschaftler, Westfälische Wilhelms-Universität, Institut für Pharmazeutische Chemie, Hittorfstraße 58-62, 48149, Münster, Deutschland

    Eugen J. Verspohl

  150. Finkenweg 11, 95119, Naila, Deutschland

    Sabine Vogel

  151. Pharmazeutisches Institut, Albert-Ludwigs-Universität, Hermann-Herder-Straße 9, 79104, Freiburg, Deutschland

    Franz-Josef Volk

  152. Institut für Pharmazie, Humboldt-Universität zu Berlin, Goethestraße 54, 13086, Berlin, Deutschland

    Thomas Vorwerk

  153. Fregestraße 80, 12159, Berlin, Deutschland

    Jürgen Wallmann

  154. WEH: Institut für Pharmazie, Königin-Luise-Straße 2 + 4, 14195, Berlin, Deutschland

    Martin Wenzel

  155. Am Rittweg 10, 77654, Offenburg, Deutschland

    Marion Weyandt-Spangenberg

  156. Am Ludwigsland 4, 96364, Marktrodach, Deutschland

    Sandra Wich

  157. Institut für Pharmazeutische Chemie, Karl-Franzens-Universität, Schubertsstraße 1, 8010, Graz, Austria

    Reinhold Wintersteiger

  158. Rappoltsweiler Winkel 5, 68229, Mannheim, Deutschland

    Frauke Woltmann

  159. Pharmazeutisches Institut, Kreuzbergweg 26, 53115, Bonn, Deutschland

    Beate Wüst

  160. Institut für Immunologie, Im Neuenheimer Feld 305, 69120, Heidelberg, Deutschland

    G. Zilow

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

von Bruchhausen, F. et al. (1999). L. In: von Bruchhausen, F., et al. Hagers Handbuch der Pharmazeutischen Praxis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58388-9_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-58388-9_1

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-63569-4

  • Online ISBN: 978-3-642-58388-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation